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GENERAL INTRODUCTION 
Since the beginning of this century the prognosis of breast cancer has 
gradually improved. This improvement most likely is partly due to an 
improvement of the surgical technique promoted by Halsted in 1891, 
partly due to the fact that women present themselves in earlier stages 
of breast cancer (Henderson and Canellos 1980). 
It is well known that the prognosis of breast cancer is mainly depen-
dent upon the stage in which the patient comes for treatment. Since 
over 9096 of all breast cancers are discovered by the woman herself as 
a palpable mass, this prognosis improvement is presumably mainly a 
consequence of better medical care, better instruction and better 
understanding of the women in general. However it is astonishing that 
in the last 30 years this gradual prognosis improvement has come to 
an end, both in the U.S.A. and in Western Europe. 
In spite of considerably improved surgical and radiotherapeutical 
techniques we did not succeed in reducing the mortality rate of breast 
cancer. A plausible explanation for this rather disappointing fact is, 
that it has not been possible to move the stage in which women come 
for treatment further forward anymore, because we have reached the 
frontiers of palpation. 
The most important result of the population screening in Leiden in 
1975 is, that it has proved that palpation, - until recently the main 
technique for detection of breast cancer-, is not a suitable instrument 
for early detection of breast cancer. 
In the past 10 years, mammography has been developed into the 
most reliable technique for early detection of breast cancer. It was 
logical, to use this technique at the population screening for breast 
cancer in Nijmegen. 
The results of its first 6 years, 1975-1980, are published and com-
mented in this book. Of course it is still too early to establish a decrease 
in mortality rate from breast cancer in Nijmegen. The favourable 
results however, allow the expectation that it will not take long before 
such a statement can be made. 
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Chapter 1 
THE AIM OF POPULATION SCREENING IN GENERAL 
AND OF POPULATION SCREENING FOR BREAST 
CANCER IN PARTICULAR 
1.1. Introduction 
Population screening means systematic investigation of a large popu-
lation group for the occurrence of a certain disease. In view of the 
burden to the population and the costs involved, it is clear that the 
investigation must entail a real benefit for the population, generally 
expressed in a higher survival rate. At the same time, the disadvan-
tages of participation should be neglectable in respect to the advan-
tages. 
In 1968 Wilson and Jungner created for the World Health Organiz-
ation a number of conditions that should be followed as much as 
possible in every population screening: 
1. The disease that is the subject of the research has to be an im-
portant health problem. 
2. There has to be a generally accepted treatment for patients in 
which the disease has been discovered. 
3. The possibilities for further diagnosis and treatment must be 
present. 
4. The disease must have a clearly recognizable preclinical phase. 
5. There must be a suitable test- or research method. 
6. The research method has to be acceptable for the population. 
7. The course of the disease, the development from the preclinical to 
the clinical phase must be known sufficiently. 
8. There should be a generally accepted strategy for the question, 
who ought to be treated as a patient. 
9. The costs of finding people with the disease, - including further 
diagnosis and treatment -, has to be economically justified in rela-
tion to the total expense of the national health care. 
10. There must be a guarantee for continuing. 
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In the last 10 years population screening for various kinds of cancer, 
such as cervical cancer, lung cancer, colon cancer, prostate cancer and 
breast cancer have been propagated. 
Reason for this is the growing notion, that in the near future no 
further improvement of the prognosis of all these forms of cancer can 
be expected with the present therapeutic possibilities and that dis­
covery of cancer in an earlier phase is the only means to improve 
prognosis. 
1.2. Why population screening for breast cancer? 
In the Netherlands breast cancer is an important health problem. From 
1960 until 1972 a reasonably reliable registration of all new cases was 
kept in the province of Friesland and in the major cities The Hague and 
Rotterdam (see figure 1). From this data it can be calculated, that in 
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Figure 1 The incidence of breast cancer, per 100 ,000 women per age-group in the 
province of Friesland and in The Hague and Rotterdam, 1 9 6 0 - 1 9 7 2 
Taken f rom 'Mammacarcmoom' (Zee van der, 1 976) Staff Department Epidemiology 
and Informatica (V Ο M I L) 
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all of the Netherlands every year about 5,000 new breast cancer cases 
are detected. This is about 25% of all malignancies in women. 
The chance for a woman to have breast cancer before she is 80 years 
old is at least 7.4%. This means that breast cancer will be found in 1 
out of every 14 women in the Netherlands during her life time. 
Breast cancer is also a main cause of death in women in the Nether-
lands. The information of the Central Office for Statistics (C.B.S.) 
shows that during 1979 in the Netherlands 2,610 women died from 
breast malignancies. This is 5.2% of all women who died in 1979. In 
1950 still only 3.8% of the total mortality of women was caused by 
breast cancer. From these percentages it can not be concluded, that 
there is an increase in the mortality rate by breast cancer since 1950 
(Van Putten et al. 1981). 
Table 1. Breast cancer mortality rate per age-group, per 100,000 women (Van 
Putten et al. 1981). 
1950 
1960 
1970 
1978 
35-39 year 
13 
11 
15 
13 
50-54 year 
55 
58 
74 
63 
65-69 year 
116 
98 
99 
115 
The mortality rate, specified per age-group per 100,000 women, 
caused by mammary cancer has hardly changed in the last 30 years in 
the Netherlands (see table 1 and figure 2 and 3). 
Death by other causes than breast cancer has strongly decreased 
during this period, through which the fraction of deaths by breast 
cancer in the total mortality has now nearly doubled (see table 2). 
Cutler and Myers (1975) found an unchanged mortality rate in 
breast cancer in the United States since 1955 as well. The 5-year 
Table 2. Percentage of deaths caused by breast cancer in comparison to the 
total deaths in each age-group (Van Putten et al. 1981). 
35-39 year 50-54 year 65-69 year 
1946-1950 7% 10% 4% 
1978 14% 17% 8% 
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Figure 2 Mortality from malignant tumors in the breast (breast cancer as primary 
cause of death) 
Information from the Staff Department Epidemiology and Informatica (VO M I L) 
survival rates of patients with breast cancer in the U S A increased 
from 53% in 1940-1949 to 6096 in the period 1950-1959, but has not 
increased perceptibly since then 
1 3 Can the prognosis of breast cancer be improved? 
Because the cause of mammary cancer is unknown, primary preven­
tion is not one of the means to improve the prognosis While reading 
the excellent survey by Henderson and Cannellos (1980) in the New 
England Journal of Medicine, one realizes that within the next couple 
of years even the advanced treatment methods we now have, do not 
allow us to expect improvement of the prognosis 
Therefore the only possibility for prognosis improvement is sec­
ondary prevention, which means treatment of breast cancer in an 
earlier, preferably preclinical phase Almost all follow-up studies show 
that the prognosis of breast cancer mainly depends upon the stage of 
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Figure 3 Malignant neoplasms of the breast Mortality rate per age-group per 
100,000 women, 1950-1978. 
Information from the Staff Department Epidemiology and Informatica (V.O M.I.L). 
the tumor when the patient comes for treatment (Fisher et al. 1975, 
see table 3; Adair et al. 1974, Say and Donegan 1974, Duncan and 
Kerr 1976,Wallgren et al. 1976, Attiyeh et al. 1977, Frazier étal. 1977, 
Langlands and Kerr 1978). 
In the Netherlands about 98% of all breast cancers are still dis-
covered by the woman herself. When she turns to her doctor with 
her complaints, - mostly a palpable tumor - , it is she who starts the 
whole process that leads to the diagnosis of breast cancer. 
Nowadays it is naive to believe that better information can lead to 
the fact that women come for treatment at an earlier stage. More so 
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Table 3 Survival of Patients with Breast Cancer Relative to Clinical and 
Histologic Stage (Taken from Fisher 1975) 
Clinical Staging 
(American Joint Committee) 
Crude Range of 
5 Yr Survival (%) 
Sui vivai (%) 
Stage I 
Tumor < 2 cm in diameter 
Nodes, if present, not felt to contain metastases 
Without distant metastases 
85 82-94 
Stage 11 
Tumors < 5 cm in diameter 
Nodes, if palpable, not fixed 
Without distant metastases 
66 47-74 
Stage III 
Tumor ^ 5 cm or, 
Tumor any size with invasion of skin 
to chest wall 
Nodes in supraclavicular area 
Without distant metastases 
Stage IV 
With distant metastases 
Histologic Staging 
(NSA BP)* 
All patients 
Negative axillary lymph nodes 
Positive axillary lymph nodes 
1-3 positive axillary lymph nodes 
> 4 positive axillary lymph nodes 
41 
or attached 
10 
Crude 
Suivivai (%) 
5 Y г lOYr 
63 5 45 9 
78 1 64 9 
46 5 24 9 
62 2 37 5 
32 0 13 4 
7-80 
_ 
5 Y г 
Disease-Free 
Survival (%) 
60 3 
82 3 
34 9 
50 0 
21 1 
* N S Α Β Ρ denotes National Surgical Adjuvant Breast Project 
because De Jong (1979) showed that in Leiden in a population 
screening for breast cancer by means of palpation by well trained 
people, the spreading of the breast cancers over the various stages did 
not appear to be any better than in the previous years 
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1.4. Diagnosis of breast cancer in an early, preclinical phase 
Although the cause of breast cancer is not well known there are also 
large gaps in our knowledge of the natural history and the pre-stages 
of mammary cancer. Nowadays in literature it is almost generally 
accepted that the ductal carcinoma in situ (D.C.I.S.) and the lobular 
carcinoma in situ (L.C.l.S.) can be regarded as pre-stages of invasive 
carcinoma (Gallager 1977, Gullino 1977, Moskowitz et al. 1977, 
Wheeler et al. 1974). 
time —*> ¡η situ phase invasive phase 
Figure 4 Relation between the growth rate of mammary cancer and the phase of the 
disease (Gallager 1977). 
Gallager (1977) suggests that the growth rate of mammary cancers 
in the in situ phase is slower than it is in the invasive phase (figure 4). 
There are theories that it can be caused by immunological and other 
defence mechanisms. 
If one accepts the hypothesis that metastases of mammary cancer 
do not start before the infiltrative or invasive phase, it is important for 
the prognosis that the diagnosis is as much as possible moved forward 
towards the early invasive (^ 1 cm) and the in situ phase. 
Unfortunately more than 95% of all breast cancers are not palpable 
at this phase. Palpation therefore is not a suitable method for early 
diagnosis of breast cancer and will never lead to an improvement of the 
present prognosis. 
This does not mean that palpation has no value for the diagnosis of 
mammary cancer, as over 9096 of the breast cancers in the Netherlands 
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are discovered by self-palpation. The self-examination of the breasts 
ought to be stimulated and taught intensively by the general practi-
tioner (De Jong 1979), otherwise the present prognosis of mammary 
cancer would become worse. 
At the present time the only method by which breast cancer can be 
diagnosed in the in situ- and early invasive phase is mammography 
(Feig 1979, Moskowitz 1979). Therefore it is understandable that from 
the beginning this technique has played an important role in popula-
tion screening for breast cancer. 
Improving the prognosis of the mammary cancer is now a challenge 
for every radiologist. Of course, an optimal mammographie technique 
and an optimal evaluation are a 'conditio sine qua non'. 
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Chapter 2 
REVIEW OF THE RESULTS IN VARIOUS POPULATION 
SCREENING PROJECTS FOR BREAST C A N C E R IN THE 
U N I T E D STATES OF AMERICA, SWEDEN A N D 
THE N E T H E R L A N D S 
2.1 Introduction 
Population screening is a very complex entity and as a consequence 
the evaluation of the results are very difficult. 
The prolonged course of breast cancer is an extra complicating 
factor, through which important effects on the mortality rate can not 
be established until after about 10 years of accurate follow-up. This 
makes it practically impossible to compare different screening 
programs. Nevertheless there are a few parameters through which one 
can get a rough impression of the quality and the possible effect of a 
population screening. 
First of all there is the level of reliability. Next come the direct and 
indirect results of the population screening. 
2.1.1. The level of reliability 
The level of reliability can be expressed in the sensitivity, the specifi-
city and the predictive value of a positive test. 
Also the detection rate of a screening can be considered as a par-
ameter of the level of reliability. 
The sensitivity indicates the ability of the test to identify people 
carrying the disease for which is being screened. The specificity 
indicates the ability to identify people not carrying the disease. The 
predictive value indicates the percentage of true positives among people 
with a positive test. 
The detection rateai the screening indicates the amount of true posi-
tives per 1,000 screened people. 
See table 4: Cole (1978) and Rombach (1980). 
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Table 4 
Disease Present: 
Test results Yes No Total 
Positive a b a + b 
Negative с d с + d 
Total a + c b + d a + b + c + d 
Sensitivity = χ 100% 
d 
Specificity = -xl00% 
b + d 
a 
Predictive value = —- χ 10096 
a + b 
Detection rate = a 
a + b + c + d 1000 
In a screening procedure a high specificity, if possible 10096, is more 
important than a high sensitivity. The specificity concerns the ma­
jority of the people screened, namely the people without the disease, 
and the sensitivity concerns the minority carrying the disease (see 
Cole and Morisson 1978). 
Rombach (1980) showed that the sensitivity and the specificity are 
mutually dependent values and that they are both strongly dependent 
upon the diagnostic criteria. If the diagnostic threshold is increased, -
what means fewer doubtful cases indicated as possible malignancies 
through which more people carrying the disease are not discovered -, 
the sensitivity decreases and the specificity increases. If one tries to 
discover more people with lesions by lowering the diagnostic criteria, 
then the sensitivity increases and the specificity of the screening 
procedure decreases. See also Lusted (1960) and Eddy (1980). 
If the consequence of a positive test is an expensive and possibly a 
harmful diagnostic procedure like biopsy and hospital admission, it 
should be aimed at an as high as possible predictive value. 
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2.1.2. The direct and indirect results of population screening 
Beside the detection rate, expressed by the number of cancers found 
per 1,000 investigated people, the following factors should be counted 
among the results of a population screening: 
- The distribution of the tumors found by the screening over different 
stages ; 
- The decrease of the chance of dying during the first years after the 
screening; 
- In the long run a lower mortality in the screened group. 
The latter is the most important factor. 
A population screening program can be considered effective only if 
the detected tumors are in an earlier stage than before the start of the 
screening. In other words, the tumors diagnosed at the population 
screening program have to be considerably smaller in diameter than 
those found outside the population screening program. Also, the 
percentage of patients with positive axillary lymph nodes have to be 
smaller. 
If the mortality rate of women who have been detected in the 
screening is not considerably lower during the first years after the 
population screening than the mortality rate of symptomatic patients, 
the chance of a reduced mortality in the screened group is small. 
Unfortunately the judgement of the effect of the screening on the 
mortality rate is especially complicated due to two biases, the so-called 
lead time bias and the length-bias. Both are direct consequences of the 
screening procedure. 
The lead time indicates the period of time by which the diagnosis is 
brought forward, due to the screening. See figure 5 according to Feig 
(1979). 
Because of the lead time, one can get the impression of an apparent 
prognosis improvement over the short term, while the final mortality 
rate has not been influenced. 
Because of this, a correction with the lead time is necessary when 
making a survival curve of patients in which tumors were found by 
screening. Of course it is necessary to be able to make a reasonable esti-
mation for the lead time. 
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lime LEAD TIME 
Beginning of Detection in Detection because of 
preclinical phase screening clinical symptoms 
Figure 5 
The length-bias is related to the fact that slow growing tumors stay 
in the preclinical phase longer than the fast growing ones. Because of 
this they have a greater chance of being discovered by screening. See 
figure 6 (Feig et al. 1978, Feig 1979). 
If one accepts the theory that the growth rate of tumors in the pre-
clinical and in the clinical phase stays the same - which is doubt-
ful (Gallager 1977) - the slower growing tumors would have a better 
prognosis than the faster growing ones. Since in screening more 
slow-growing tumors are detected, screening can result in an apparent 
prognosis improvement. 
Many problems that occur in the interpretation of a population 
screening program can be avoided by setting up the screening as a so-
called 'randomized controlled trial'. With this system one proceeds 
with two population groups that are as equal as possible. One of these 
groups is screened and the other one functions as a control group. 
-•TIME 
SCREENING POINT 
Figure 6 The effect of the length of the preclinical phase on the chance of detection 
in screening (length-biased sampling) 
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After a few years the effect of the screening can be measured in the 
form of a decreased mortality rate in the screened group. Unfortu-
nately such a design is often impossible for various reasons, in particu-
lar for medical ethical reasons. 
2.2. Population screening programs for breast cancer in the 
United States of America 
2.2.1 The H.LP. study 
The population screening for breast cancer from the 'Health Insurance 
Plan' in New York up till now is still one of the best documented popu-
lation screening programs for breast cancer. 
This study started in December 1963 as a randomized controlled 
trial, with the aim to show that regular population screening by means 
of mammography and physical examination, could cause a decrease in 
the mortality rate by breast cancer in the screened group. 
Of the members of the 'Health Insurance Plan of Greater New York' 
an at random choice into two groups of women between 40 and 
64 years old had been made. Each group consisted of about 30,000 
women. Four times the study group was invited for a yearly screening 
for breast cancer. The control group could use the normal medical 
provisions. The screening consisted of anamnesis, physical examin-
ation and of mammography in two projections of each breast. One has 
to keep in mind that the technique of mammography in 1963 was still 
in its developmental stage. 
Egan's technique (1963) was practised with an average skin dose of 
7.7 Rad. = 0.077 Gy. The midbreast dose at a depth of 3 cm was 2 Rad. 
= 0.02 Gy. (Upton et al. 1977). 
The results of the H.I.P. study were extensively published by 
Shapiro (1966, 1971, 1976, 1977 and 1978). 
The total number of women in the study group was 31,092, the 
number of participants in the first screening round was 20,211. This 
resulted in an attendance percentage of 6596. This percentage dropped 
to 45% by the fourth screening. The detection rate was (Shapiro 1977): 
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Table 5. Diagnosed cancers (Shapiro 1977) 
Study group 
1st. screening 
2-4th. screening 
Interval 
Non-participants 
Total study group 
Control group 
Number 
55 
77 
93 
74 
299 
285 
%o 
2.73 
1.49 
0.93 
1.45 
1.87 
Compared to our results, this is a very low detection rate, probably 
mainly caused by the primitive equipment ofthat time. The sensitivity 
of the H.I.P. study for all four screenings combined varied between 
7596 and 9596. 
The specificity was about 9996 (Van Putten et al. 1981). About 5096 
of the tumors found by screening were smaller than 2 cm, and only 
2096 in the control group were smaller. 70% of the patients found by 
screening had negative axillary nodes, in contrast with only 4596 in the 
control group (Thomas et al. 1977). Within 10 years after the begin-
ning of the H.I.P. population screening a reduction of about 3096 in 
mortality rate from breast cancer had been noted. 
Table 6. H.I.P. study: Number of deaths from breast cancer, in the study 
group and control group. 10 years follow-up. 
Age at the first screening 
40-49 50-59 60-64 Total 
Study group 
Control group 
96 death reduction 
because of screening 
42 
54 
1996 
43 
63 
3296 
12 
22 
4596 
97 
137 
29% 
The conclusion that women in the age-group between 40 and 49 
would have no advantage from the screening (De Jong 1979, Zwave-
ling et al. 1981) is not justified on account of these figures (Van Putten 
et al. 1981). 
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2 2 2 The 'Breast Cancer Detection Demonstration Projects' 
(В С D D Ρ) in the United States oj America 
When the favourable effect of screening for breast cancer became clear 
10 years after the start of the Η I Ρ study, the American Cancer 
Society ( A C S ) and the National Cancer Institute ( N C I ) organized 
the so-called 'Breast Cancer Detection Demonstration Projects' 
(В С D D Ρ ) 
An important aim of this project is to show doctors and women the 
possibility of population screening on a large scale for the early detec­
tion of breast cancer 
Most of the in total 29 screening centers began their activities 
between July 1973 and October 1974 Every center offered 10,000 
women in the age-group of 35-74 years the possibility of a yearly 
screening during 5 years, with a follow-up during 5 years after that It 
concerned women without complaints of the breast, coming without 
personal invitation The annual screening consisted of a physical 
examination, a mammogram and a thermogram 
Since the Η I Ρ study the quality of mammography had been greatly 
improved and the required X-ray dose had been decreased The 
average midbreast dose from two exposures varied in different centers 
from 0 25-0 72 Rad (0 002-0 007 Gy ) Xeromammography as well as 
film-screen combinations were used in the В С D D Ρ The results of 
the first two rounds are now known (Beahrs et al 1979) 
The detection rate per age-group was as follows 
Table 7 Detection rate per 1000 
<ζβ-group 
35-39 
40-44 
45-49 
50-54 
55-59 
60 64 
65-74 
Total 
First 
round 
1 50 
3 12 
5 87 
5 54 
7 48 
7 98 
11 25 
5 84 
(843) 
Second 
round 
0 57 
104 
2 12 
2 46 
2 33 
2 86 
2 78 
1 99 
(247) 
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The number of interval cancers after the first- and second round were 
145 and 73. 
The sensitivity of the screening in the first round was 85% and in the 
second round 77%. In the first round 93% of the tumors were dis-
covered by mammography versus 56% by palpation. In the second 
round 97% of the tumors were found by mammography and 50% by 
palpation. In contrast with the findings of the H.I.P. study, in the 
B.C.D.D.P. only 7.4% of the cancers in the first round and 3% in the 
second round were added to the detection rate by palpation. In women 
younger than 50 years 46% of the cancers were discovered only by 
means of mammography in the first round, 54% in the second 
round. 
More than half the cancers found by the B.C.D.D.P. were not 
palpable. 'Minimal cancers', non infiltrated so-called 'in situ' cancers 
and infiltrated cancers smaller than 1 cm in diameter, in both rounds 
accounted for about 35% of the total amount of cancers. 70% of the 
patients found with breast cancer at the B.C.D.D.P. had negative axil-
lary lymph nodes. 
From the observations described above it is evident that an enor-
mous improvement in quality of mammography has occured since the 
H.I.P. study. 
2.3. The population screening for breast cancer in Sweden 
Unlike the population screening in America, in Sweden the only detec-
tion method is mammography. 
2.3.1. The population screening in Malmö 
The population screening in Malmö, a city with 240,000 inhabitants, 
started in January 1977. The results of the first round are described by 
Andersson et al. (1979), Andersson (1980). 
This investigation consists, just like the H.I.P. study, of a rando-
mized controlled trial, which means that 50% of all women between 45 
and 69 years old are invited for screening, whereas the other 50% form 
the control group. 
In Malmö two views of each breast are taken, a craniocaudal and a 
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mediolateral oblique projection, as is extensively described by Lund-
gren and Jakobsson (1976), Lundgren (1977, 1979). 
The results of the first round of this population screening are shown 
in Andersson's figure (1980). See figure 7. 
The attendance rate in the first screening round was 74%. The 
detection rate of cancers in the age-group of 45-69 was 7.5 per 1000 and 
it varied from 4.7/1000 in the group of 45-49 up to 11 6/1000 in the 
group of 65-69. Within one year after a negative screening, 11 interval 
cancers were discovered. Out of this, a sensitivity can be calculated of 
91.596 and a specificity of 91.4%. The supplementary complete mammo­
graphy raised specificity to 99.2%. The predictive value of a suspect 
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mammography at the screening was 22 396 The predictive value of a 
complete positive mammogram was 47 2% 
Non invasive tumors or invasive tumors smaller than 1 cm 
accounted for 59% of the tumors found by screening Axillary lymph 
nodes were negative in 82% of the patients with mammary cancer 
In the control group 51 cancers occured, 84% of these were larger 
than 1 cm There were no in situ cancers among them The average 
size of the tumors found in the control group was 2 cm 47% of the 
patients in the control group had positive axillary lymph nodes 
2 3 2 The population screening m Kopparberg County 
The population screening in Kopparberg County, situated in the 
middle of Sweden, is described by Tabar (1981) This is also a rando-
mized controlled trial, but here the randomization is based on as 
comparable as possible population groups Only one mammographie 
projection, - the mediolateral oblique one from Lundgren (1976) -, is 
used 
The investigation started in October 1977 AH women above the age 
of 39 in a selected area were invited The results of the first round are 
given in Tabár's figure (1981) See figure 8 
The attendance rate was 84 3% The detection rate was 7/1000 In the 
age-group of 40-49 the detection rate was 2 3/1000 and above 75 years 
of age it was 12 4/1000 Within one year after a negative screening 13 
interval cancers were discovered This gives a sensitivity of 95 5% and 
a specificity of 98 9% 39 6% of the tumors detected were non invasive 
or smaller than 1 cm in diameter The predictive value of a suspect 
mammogram at the screening was 14%, after complete mammography 
38% Only 18 9% of the women who were detected by the screening 
had positive axillary lymph nodes 
In the control group (22,658 women) only 74 breast cancers were 
diagnosed during the first round of screening 52% of these tumors 
were larger than 2 cm 11% were so-called 'minimal cancers' 31 5% of 
the patients from the control group had lymph node metastases and in 
20 6% the axilla was not investigated 
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2.4. Population screening for breast cancer in the Netherlands 
2.4.1. The D.O.M. project (Diagnostisch Onderzoek Mammacarcinoom 
= diagnostic investigation of mammary cancer) in Utrecht 
This population screening for breast cancer was started in December 
1974, the results of the first round are described by De Waard et al. 
(1977, 1978), Rombach (1980) and Collette et al. (1982). 
For this investigation only women between the ages of 50 to 64 were 
invited. The investigation consisted of anamnesis, palpation and 
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Xeromammography. Mean integrated dose 0.65 Rad. (0.007 Gy.) per 
exposure. In the first round two projections, a craniocaudal and a 
mediolateral projection, of each breast were taken. 
The attendance rate of the first round was 71.596. The detection rate 
of cancers was 7.6/1000. The sensitivity of the screening procedure was 
96%, the specificity was 99%. 
The predictive value was about 42%. Most cancers (58%) were 
detected only by means of mammography. Only one cancer would 
have been missed if palpation had been left out (Rombach 1980). 39% 
of the cancers were 'minimal cancers', which means intraductal or 
invasive and smaller than 1 cm. 66% of the patients had a negative axil­
lary status at surgery; no information was available about the axillary 
status in 10%. 
2.4.2. The population screening for breast cancer in Leiden 
In 1975 in Leiden a population screening for breast cancer was set up 
for women above 35 years of age. 
Invited 23.079 
Attended 15,971 
1 Ftalp lesions 
wRisk factor 
-3.945 
\ Examined by doctor 
I Indication for mammography 
Ц in hospital 
2,446 
I Biopsy unknown 
4 Carcinomas 
42 
Figure 9 
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This investigation consisted of a careful anamnesis and a physical 
examination (inspection and palpation). 
The results of this screening were described by Zwaveling and 
Kleinveld in 1976 and De Jong in 1979 (see figure 9). 
Since no information is available about interval carcinomas within 
12 months after a negative screening, the sensitivity and specificity of 
the screening in Leiden unfortunately can not be calculated. The 
predictive value is only 1.7% if we consider the referral for mammo-
graphy to the hospital as a positive test result. The detection rate was 
2.6 per 1000 women. The average tumor size appeared to be slightly 
larger than the tumors diagnosed outside screening, 3.7 to 2.8 cm. JVo 
'minimal cancers' were detected. 50% of the patients detected by 
screening had a positive axillary status. 
The most important conclusion of the investigation in Leiden is that 
palpation is not a suitable screening method for early detection of 
breast cancer. 
In view of the low predictive value of palpation in the detection of 
mammary cancers in a non selected population, the effect of routine 
investigation of the breasts by general practitioners for earlier detec-
tion of breast cancer is questionable (Zwaveling et al. 1981, Kliniek 
van Mammatumoren, page 87). 
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Chapter 3 
ORGANIZATION OF THE POPULATION SCREENING 
FOR BREAST CANCER IN NIJMEGEN 
3.1. Introduction 
In February 1970 in the Department of Diagnostic Radiology in the 
St. Radboud University Hospital in Nijmegen, modern mammography 
equipment with a molybdenumanode was installed. Since that time 
the demand for mammography both from inside the hospital as well 
as from outside the hospital by general practitioners, has strongly risen 
(see table 8). 
Table 8. Increase in the number of mammographies, each year from 1970 
until 1974 in the Radiology Department: 
1970 
1971 
1972 
1973 
1974 
230 
600 
1,050 
1,330 
2,600 
The most important cause of this rise was that with the help of 
modern mammography technique, a malignant tumor in the breast 
could be shown or excluded with a high degree of reliability. 
In 97% of the 141 pathologically confirmed cancers in the years 1972, 
1973, 1974, the mammographie diagnosis turned out to have been 
correct. 
18% of the cancers were not palpable but were detected on the 
mammogram. Almost all cancers found by mammography only, were 
in stage 1. This early detection and the still rather poor prognosis of 
mammary cancer, - mainly based on the fact that metastases often 
had occurred before detection -, made us think of the possibility 
of prognosis improvement of breast cancer by population screen-
ing. 
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Also the first publications on the H.I.P. study by Shapiro in 1971 
supported us in these expectations. The more so, because it seemed to 
us that the quality of mammography since the H.I.P. study had 
improved incomparably. 
Finally in 1974, because of the introduction of film-screen combina-
tions in mammography, the required X-ray dose had so much 
decreased that the possible harmful effects became relatively small. 
All this had been a reason for us to examine the possibility of using 
mammography as the only detection method in a population screening 
program for breast cancer. 
3.2.1. Primary Organization, Financing and Administration 
After extensive study of the possibilities and modalities a request for 
financial support was launched to the Prevention Fund. Once this was 
given, arrangements were made with the City of Nijmegen for space 
in the municipal health center and for administrative help. 
The invitations for women of the City of Nijmegen in the population 
screening for breast cancer were made by the Town Council of 
Nijmegen. The appointments were sent by the information system at 
the Center for Automation East Holland (C.O.N.), that handles the 
population administration for Nijmegen. 
For the population screening this center has produced a so-called 
basic register, consisting of the personal information of the women 
living in Nijmegen and born before 1-1-1940. This register was updated 
every month for moving, leaving, death, marriage and divorce muta-
tions. Appointment cards and computer cards were made up per area 
and sorted out per street and per house number. In such a way that 
women were invited streetwise. It was expected that mutual contacts 
in the street would stimulate participation. 
The appointment cards (see for an example Appendix A) were sent 
out by the Town Council of Nijmegen. The system of inviting the 
women has started in area 00 (center), then area 01 (down town) et-
cetera (for an example of the appointment system see Appendix B). 
If the women did not respond to the appointment, a repeated 
appointment was to be sent out (Appendix C). All women of the above 
mentioned age-group that moved to Nijmegen during the screening 
period were invited. 
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For every woman invited the working group received a computer 
card (example Appendix D). This was used for identification of the X-
ray films, for addressing and for feeding the personal data into the 
medical information file that was to be built up with the help of the 
computer center of the St. Radboud University Hospital. 
3.2.2. Processing anamnesis. X-ray diagnosis and data from general 
practitioners, surgeons and pathologists 
During the first round (1975-1976) an extensive questionary was filled 
in before mammography, with the help of a doctors assistant (see for 
an example Appendix E 1, E 2, E 3). 
This form contains a number of questions, important for reporting 
of the X-rays and a number of questions concerning the possible risk 
factors. Data from the questionary and information from the mammo-
graphie report (see for an example Appendix F 1, F 2, F 3), were 
recorded in the medical register. 
The lay-out of the forms was such that it easily could be processed 
and retrieved by means of punch cards. During the next rounds of the 
screening a shortened questionary (see for an example Appendix G 1, 
G 2), was sent with invitation and appointment, and the request to fill 
in at home and bring it to the screening center. 
If any abnormality was detected at the screening, the woman's 
general practitioner would receive a report within a few days of the 
localization of the lesion, the X-ray diagnosis and an advice. The form 
was in triplicate (see for an example Appendix H). Its first page had to 
be returned by the general practitioner to the screening center, men-
tioning the surgeon and the hospital to which the woman was sent. 
The second page had to be kept by the general practitioner and the 
third page could be used by the general practitioner to refer the 
patient to the surgeon. 
One day after the report to the general practitioner a letter was sent 
to the woman with the advice to contact her general practitioner (see 
for an example Appendix I). Every week - with one week delay - all 
general practitioners received a list of all women examined in their 
practice including both normals and abnormals. 
A special form (see for an example Appendix J) was designed for the 
surgeons, with requests about data from examination and operation. 
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These data, together with the information from the pathologist were 
recorded in the medical register. For a survey, see scheme population 
screening Nijmegen Appendix K. 
The costs of the population screening for breast cancer in Nijmegen 
with a capacity of 10,000 examinations per year were/40.- per woman. 
This includes the computer costs for scientific investigation. The 
Town Council charged every woman ƒ 2.50 for administration costs 
etc. Since January 1982 these were increased to ƒ 10.-. 
The population screening was made possible both by the financial 
help of the Prevention Fund and later on also by the Ministry of 
Health, and the administrative help from the Town Council of 
Nijmegen. 
3.3. X-ray techniques at the population screening center 
3.3.1. Mammography techniques 
Since the early diagnosis of a malignant lesion is the essential point in 
a population screening for breast cancer, optimal mammographie tech-
nique is required to show minimal lesions like small groups of micro-
calcifications. 
Apart from the X-ray technical factors like modern equipment, 
correct exposure, an ideal film-screen combination and optimal devel-
opment, the quality of the mammogram is for a great deal dependent 
upon careful positioninghy the radiographer. Since automatic exposure 
and an increased reliability of modern processors had resulted in a 
constant film quality in the last few years, positioning became the 
most important factor for a good mammogram. 
Based on our clinical experience from the beginning we have utilized 
special mammographie equipment with a molybdenumanode and a so-
called lo-dose film-screen combination. The films can be developed in 
90 seconds. 
For mammography in the Department of Diagnostic Radiology 
of the St. Radboud University Hospital in Nijmegen, generally two 
views, one craniocaudal- and one lateromedial view of each breast 
were taken. Only on special indication a third view of the axilla and 
axillary tail was made in the ventrodorsal projection. Two projections 
not only make diagnosis easier, they are also necessary for the exact 
localization of the lesion. 
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The examination of the axillary tail and the axilla gives information 
about tumors and metastases in that area. Unlike many other centers, 
we make the lateral view in the lateromedial projection, and not in the 
mediolateral projection. In series of patients in which both the medio-
lateral and the lateromedial projection were made, it turned out that 
the lateromedial view often showed more mamma tissue than the 
mediolateral view. 
This can be explained by the construction of the mammographie 
equipment on one hand and the anatomy of the chest and breasts on 
the other hand. In particular it became clear that the compression of 
the breast with the help of the compression plate was easier from the 
lateral side, - where the mamma is more mobile -, whereas the fixed 
plate that keeps the cassette can better be adapted to the sternum. 
In an investigation on 100 consecutive breast cancers diagnosed in 
the University Hospital Department of Diagnostic Radiology, 94 
cancers were visible on the lateromedial projection, 89 on the cranio-
caudal projection and 26 on the projection of the axillary tail. 
The localization of these 100 cancers were as follows: 
ventrodorsal view (26) 
У 
/ 
¿0 
rd h 
ІЭ 
7 
26 
e craniocaudal view (89) 
lateromedial view (94) 
Figure 1 0 
On the lateromedial film all 94 cancers localized in the breast were 
shown, the 6 cancers in the axillary tail were not shown. On the 
craniocaudal projection 89 of the cancers localized in the breast were 
shown, the 6 localized in the axillary tail as well as the 3 in the lateral 
upper quadrant and the 2 in the medial upper quadrant were not 
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shown. All cancers localized in the axillary tail and the axilla were 
shown on the ventrodorsal projection ofthat area. On the latter projec-
tion 18 tumors in the lateral upper quadrant and 2 of the central tumors 
were also seen. 
On account of the results of this investigation and because of radi-
ation protection considerations, we decided to take only one view of 
every breast in the lateromedial projection. 
The films were processed immediately and studied by the radi-
ographer. If there were no lesions to be discovered on this film the 
examination was finished. 
An extra view in craniocaudal direction of both breasts was made if 
one of the lateral projections was not good enough for evaluation 
because of quality or overprojection or if there was a lesion. The 
frequency of this second projection varied with the experience of the 
radiographer and the occurrence of dysplasias, but it was never higher 
than 5% of the examinations. Because of this procedure we managed 
to reduce the netto time required for the X-ray examination to an 
average of 5 minutes and to reduce the radiation dose by 5096. 
Technical information concerning mammography: 
X-ray equipment: Senographe (C.G.R.) 
Exposure: 30 kV 
30 mA 
Automatic exposure 
X-ray film 1st. round: Lo-dose I film + screen (Dupont) 
2nd. and 3rd. round: Min R film + screen (Kodak) 
Developing machine: Kodak X-omat model 100 with 
Kodak chemicals 
Developing time: 90 seconds 
Developer temperature: 34°C. 
3.4. Exposures and estimated radiation risks 
In every X-ray examination the risk of the ionizing radiation should be 
weighed against the possible benefit of the examination for the patient. 
An expert X-ray examination will practically never involve a radiation 
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risk that is comparable with the risk of omitting the examination if 
there is a good indication. However, the situation is different when 
healthy people are examined, especially when this is done at regular 
intervals and a cumulative effect of the radiation can be expected. This 
is why we thought it important to get an idea of the possible radiation 
damage before starting the population screening. 
In general X-rays can cause genetic and somatic damage. The 
genetic damage arises when the gonads are situated in the direct X-ray 
beam or are hit by scattered radiation. Fortunately this does not 
happen in mammography. Because of the construction of the equip­
ment all direct radiation falling outside the breast is absorbed. As the 
primary radiation is generated at only 30 kV, there is hardly any scat­
tered radiation. Mammography can not cause any genetic damage, 
because very weak radiation can not penetrate into the ovary. 
In the assessment of the possible somatic damage caused by 
mammography we have to keep in mind that in modern mammo­
graphy only the breast receives radiation and that the radiation does 
not reach any other organs. The skin receives the highest dose, an 
average of 0.5 Rad. per projection on lo-dose film, at the plane of entry 
of the beam. 
For calculation of the risk, not the skin dose but only the integral 
dose on the glandular tissue is important (Hammerstein 1979). This 
dose is an average of 20% of the entry dose = 0.1 Rad. Based on the data 
from the B.E.I.R. report (1972) and the Unscear report (1977) a risk of 
6.6-8.7 induced tumors per IO6 women per Rad. per year was calcu­
lated. If the mammogram is made with a dose of 0.1 rad, and the 
survival rate is supposed to be 75%, the average chance of death per 
year in the risk period will be 1.7 χ IO"6 as a consequence of screening 
women from the age of 35 every 2 years (Gezondheidsraad 1982). This 
risk is one magnitude smaller than other acceptable or unavoidable 
risks. 
e.g. : 
- The chance of a fatal traffic accident (23 χ 10 Vyear) 
- The chance of a fatal accident by natural causes (0.14 χ lO'Vyear) 
- The chance of an accident at work (4 χ lO'Vyear) or an accident in 
the house (16 χ lO'Vyear). 
(C.B.S. information on the period 1950-1973.) 
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In our opinion the risk of induction of tumors is almost neglectable 
compared to the benefits expected from a population screening on 
breast cancer. 
Since in the Netherlands for mammography almost only film-screen 
combinations are used, - with an exposure of the glandular tissue of 
0.1 Rad. or less -, the question arises what is the aim of reference to 
the risk of mammography in Zwavelings 'Kliniek van Mammatu-
moren', page 64, 81. It might be a somewhat slow reaction on the 
mammography-psychosis that broke out in the U.S.A. after the publi-
cation of Bailar (1976). Meanwhile already in 1977 and 1978 van 
Bekkum published that the situation concerning the radiation dose in 
the Netherlands was fundamentally different from the one in the 
U.S.A. 
3.5. Reporting technique of the Radiologists and Radiographers 
3.5.1. Reporting by Radiologists 
The reporting of a mammogram from the population screening center 
differs from that of a mammogram in the hospital in a few points only. 
First of all no palpation information is given, unlike mammography 
from patients. Reporting the mammogram is practically the same as in 
the hospital except that generally there is only one film per breast. 
Necessary for reporting are a viewing box with normal light intensity 
and an even light distribution, and a 2 times magnifying glass with a 
diameter of 10-12 cm, enabling one to see through it with both eyes 
at the same time. The light intensity wanted is related to average 
density of the film. A strong lamp with an iris diafragm and adjustable 
light intensity can be very useful in reporting. 
The X-rays are positioned on the viewing box, such that the left and 
right breast can be easily compared. The first thing to look for is 
symmetry. Apart from a few exceptions, the shape of the left and right 
fibroglandular triangle is always the same. Differences in volume of 
the tissues are more often seen. Next to study is if the relation between 
glandular tissue, connective tissue and fat tissue is normal for the age 
and if there is dysplasia. Finally the films are to be scanned with a 
magnifying glass looking for groups of microcalcifications, - for dif-
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ferential diagnosis see Hoeffken and Lányi 1973, Lányi and Citaler 
1981, Lányi 1982, Sickles 1980 -. 
In case of larger tumors, one has to look for the border, the sepa-
ration of the surrounding tissue for spiculae and also for the occur-
rence of microcalcifications in or nearby the tumor. The vascular 
pattern of the left and right breast has to be compared. Further one will 
have to look for one-sided or local widenings of the milk ducts, 
because this could be an indication for malignancy. 
After completion of the study of the films the radiologist has to 
choose between the following diagnoses: 
0. Normal for the age ; 
1. Benign local lesion (cyst or fibro-adenoma) ; 
2. Benign diffuse lesion (mastopathy); 
3. Doubtful (malignancy can not be excluded); 
4. Suspect (suspicion of malignancy); 
5. Malignant (definite signs of malignancy). 
The diagnoses 3, 4 and 5 require further definite examination in the 
hospital. 
3.5.2. Reporting by Radiographers 
In the future reporting of X-rays by specially trained radiographers has 
to play a major role in a nation-wide population screening for breast 
cancer. In the first place there will not be enough experienced radi-
ologists available for reporting the enormous amounts of mammo-
grams and in the second place this will importantly reduce the cost 
factor. If pre-screening by radiographers would allow the radiologist 
to report only 10% of the mammograms made, this could even mean 
an increase in accuracy. This because when reporting is done by 
radiographers, only the abnormal mammograms are put aside, which 
enables the radiologist to spend more time with the really important 
cases. An interpretation of the pathology is not required. All the 
radiographers have to do is to recognize and put aside the abnormals 
for the radiologist. 
During the six months preceding the start of the population 
screening program in Nijmegen, the radiographers who were assigned 
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to do the selection were intensively involved in reporting the mammo­
grams in the hospital During the training of these radiographers 
symmetry between the left and the right glandular tissue and occur­
rence and recognition of small microcalcifications were highly accen­
tuated 
Once the screening had started it very rarely happened that the 
radiologist requested a second projection for correct reporting when 
the examination was reported as normal by the radiographer 
3 6 Epidemiological guidance and cancer registration 
Population screening is in the first place an epidemiological event 
That is why from the very beginning, a close co-operation with the 
Epidemiology Department of the Social Health Institute of the Univer­
sity of Nijmegen was initiated 
Reliable epidemiological information about the preceding years 
1970-1974 were necessary, to be able to check the effect of the popu­
lation screening on morbidity and mortality of breast cancer in 
Nijmegen 
Unfortunately however, a general cancer registration does not exist 
in the Netherlands In our opinion, this is a very first necessity for the 
study of cancers G Ρ Vooys, M D , pathologist at the University of 
Table 9 Nijmegen age specific incidence rates of breast cancer 1970-1974 
Age-group 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70 + 
All ages 
Population 
1970-1974 
20,266 
20,268 
20,519 
19,623 
18,137 
17,429 
15,340 
26,516 
158,098 
Number of 
breast 
canters 
1970-1974 
7 
25 
29 
30 
20 
23 
29 
70 
233 
Incidence 
per 10% 
women 
per year 
34 
123 
141 
153 
109 
132 
189 
264 
148 
45 
Table 10 Nijmegen age specific mortality rates of breast cancer 1970-1974 
Age-group Population Death from Mortality 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70 + 
All ages 
1970-1974 
20,266 
20,268 
20,519 
19,623 
18,137 
17,429 
15,340 
26,516 
158,098 
breast 
cancer 
1970-1974 
5 
3 
12 
12 
13 
10 
11 
56 
122 
per 10s 
women 
per year 
25 
15 
58 
61 
71 
57 
72 
211 
78 
See figure 11 Breast cancer incidence and mortality per 100,000 women in 
Nijmegen 1970-1974 
Nijmegen, initiated that all information about all primary breast 
cancers - detected in the years 1970-1974 - were gathered in the Pa-
thology Departments of the hospitals in Nijmegen and Arnhem 
In co-operation with B.V. Bekker M.D., epidemiologist, the inci-
dence and mortality rates in Nijmegen and Arnhem were calculated for 
the years 1970-1974 (see table 9, 10, 11, 12 and figure 11, 12). 
Table 11 Arnhem age specific incidence rates of breast cancer 1970-1974 
Age-group Population Number of Incidence 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70 + 
All ages 
1970-1974 
17,784 
19,094 
21,209 
19,803 
18,993 
17,869 
15,125 
27,262 
157,139 
breast 
cancers 
1970-1974 
14 
10 
36 
29 
29 
34 
27 
65 
244 
per 105 
women 
per year 
79 
52 
170 
146 
153 
190 
179 
238 
155 
46 
Table 12. Arnhem: age specific mortality rates of breast cancer 1970-1974. 
Age-group Population Death from Mortality 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70 + 
All ages 
¡970-1974 
17,784 
19,094 
21,209 
19,803 
18,993 
17,869 
15,125 
27,262 
157,139 
breast 
cancer 
1970-1974 
2 
1 
19 
24 
18 
10 
17 
42 
139 
per IO5 
women 
per year 
11 
37 
90 
121 
95 
56 
112 
154 
89 
See figure 12: Breast cancer incidence and mortality per 100,000 women in 
Arnhem 1970-1974. 
The incidence of breast cancer in Arnhem and Nijmegen is similar to 
the one in Friesland and The Hague - Rotterdam (see figure 1). 
The incidence mentioned in the tables above is the so-called calculated 
incidence. At the first population screening the prevalence of breast 
cancer in the examined group has been found. 
Prevalence is the number of women with breast cancer in the popu-
lation in a certain period (point-prevalence). By repeating the 
screening on the same group (2 or 3 times) in the end the real number 
of cancers detected is equal to the incidence; it is the number of new 
breast cancers developing in a certain time in the population. 
To be able to see the influence of the population screening on the 
mortality of breast cancer in Nijmegen, it is important to follow very 
accurately the mortality in the next 5 to 10 years not only in Nijmegen, 
but also in a town of comparable size and in the rest of the Nether-
lands. The mortality figures are given by C.B.S. (Central Office for 
Statistics). 
From 1-1-1975 we have registered all primary breast cancers diag-
nosed in Nijmegen with as much relevant information as possible. 
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mortality 1970 1974 
Figure 1 1 Breast cancer incidence and mortality per 100,000 women per age-group 
in Nijmegen 1970-1974 
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Figure 12 Breast cancer incidence and mortality per 100,000 women per age-group 
in Arnhem 1970-1974. 
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Chapter 4 
RESULTS OF THE POPULATION SCREENING FOR 
BREAST CANCER IN NIJMEGEN, 1975-1980 
4.1. Introduction 
In Nijmegen during the period of January 1,1975 until December 31, 
1980 population screening was performed three times with an interval 
of 2 years. For the first round, in 1975 and 1976, all women born before 
the 1st. of January 1940 and after the 1st. of January 1910 were invited 
(age-group 35-65 years). For the second round, in 1977 and 1978, all 
women born before the 1st. of January 1940 were invited. For the 
group that also participated in the first round (35-65 years old), this was 
the second examination. For the older group, of 65 years and older at 
entry, it was the first one. The latter also applies to women who did 
not react on the first invitation. 
For the third round, in 1979 and 1980, again all women born before 
the first of January 1940 were invited. For the age-group of 35-65 years 
from the first round, this was the third examination ; for the age-group 
of 65 and above this was the second examination. All women received 
an appointment again, also the ones who did not react the first two 
times. 
Meanwhile the 4th. screeninground is in progress. Therefore in the 
next few years several figures are subject to change. The following 
results should more be looked upon as relative- than as absolute 
figures. 
4.2. Attendance per age-group per round 
The overall attendance rate was: 
84.896 in the first round 
64.8% in the second round 
57.3% in the third round 
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Table 13. Attendance of the 1st. round 1975-1976. 
Age at time of examination. 
Age-group Invited Examined Percentage 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
3,170 
3,974 
4,033 
4,158 
3,598 
3,683 
589 
2,776 
3,456 
3,507 
3,538 
2,996 
2,996 
418 
Total 23,205 19,687 
87.6 
87.0 
87.0 
85.1 
83.3 
81.3 
71.0 
Average 84.8 
Table 14. Attendance of the 2nd. round 1977-1978. 
Age at time of examination. 
Age-group Invited Examined Percentage 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 + 
1,831 
3,813 
3,930 
4,049 
3,749 
3,620 
3,330 
2,724 
3,456 
1,452 
2,987 
2,994 
3,012 
2,705 
2,481 
1,987 
1,256 
877 
79.3 
78.3 
76.2 
74.4 
72.2 
68.5 
59.7 
46.1 
25,4 
Average 
72.4 
Total 
Age-group 
30,502 
Table 15. 
Invited 
19,752 Average 64.8 
Attendance of the 3rd. round 1979-1980. 
Age at time of examination. 
Examined Percentage 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 + 
234 
3,857 
3,843 
3,843 
3,970 
3,366 
3,341 
2,816 
3,563 
168 
2,883 
2,736 
2,665 
2,594 
2,070 
1,760 
984 
657 
71.8 
74.7 
71.2 
69.3 
65.3 
61.5 
52.7 
34.9 
18.4 
Average 
66.3 
Total 28,833 16,517 Average 57.3 
The attendance rate decreased gradually with the increase of age; 
above 70 years a strong decrease was observed : 
34.5% in the second round 
25.7% in the third round 
The attendance rate of the women under 70 years of age was: 
84.8% in the first round 
72.4% in the second round 
66.3% in the third round 
In view of the low attendance rate of women above 70 years of age it 
is questionable if they should be included in population screening. The 
rather high attendance rate of the younger women in comparison to 
other population screening programs suggests that the method of 
making appointments area by area, street by street, and house by 
house has had a favourable effect. 
The difference in attendance rate in the different areas of the city of 
Nijmegen is obvious. In the 1st. round the attendance rate varied from 
70% till 90% according to the area. The distance to the population 
screening center turned out to have no influence. The social status of 
the population in the area probably plays a large role, with as most 
important criteria knowledge and social integration (v.d. Heuvel 1977, 
1978, Emanual-Vink 1977). 
For a population screening program a good propaganda, - explaining 
the usefulness of the screening -, is of more influence on the decision 
to participate than the distance to the center. 
4.3. Referral for further examination to the hospital 
For evaluation of the figures of referred patients it is important to 
know if it concerns the first-, second- or third examination. This also 
applies to the study of other data. That is why we have checked at the 
second- and third round if it was a first-, second- or third examination 
(see table 16 and 17). 
With these data a table could be made of the number of women per 
age-group examined for the first-, second- and third time in the period 
1975-1980, independent of the screening round (see table 18). 
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Table 16. Attendance of the 2nd. round, divided over 2nd. and 1st. examin-
ation per age-group. Age at time of examination. 
ige-group 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 + 
Total 
2nd. exam. 
1,318 
2,795 
2,828 
2,870 
2,549 
2,342 
992 
-
-
15,694 
1st. exam. 
134 
192 
166 
142 
157 
139 
995 
1,256 
877 
4,058 
Total 
1,452 
2,987 
2,994 
3,012 
2,706 
2,481 
1,987 
1,256 
877 
19,752 
Table 17. Attendance of the 3rd. round, divided over 3rd. 2nd. and 1st. 
examination per age-group. Age at time of examination. 
Age-group 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 + 
Total 
3rd. exam. 
145 
2,443 
2,370 
2,325 
2,269 
1,795 
1,374 
-
-
12,721 
2nd. exam. 
21 
360 
291 
282 
274 
226 
330 
861 
526 
3,171 
1st. exam. 
2 
80 
75 
58 
51 
49 
56 
123 
131 
625 
Total 
168 
2,883 
2,736 
2,665 
2,594 
2,070 
1,760 
984 
657 
16,517 
Table 18. Number of women per age-group examined for the first-, second-
and third time. Age at time of examination. 
Age-group First exam. Second exam. Third exam. 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 + 
Total 
2,912 
3,728 
3,748 
3,738 
3,204 
3,184 
1,469 
1,379 
1,008 
24,370 
1,339 
3,155 
3,119 
3,152 
2,823 
2,568 
1,322 
861 
526 
18,865 
145 
2,443 
2,370 
2,325 
2,269 
1,795 
1,374 
-
-
12,721 
53 
Table 19 Referred for further investigation per age-group at 1st examination 
Age at time of examination 
Age-group 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 + 
Total 
First exam 
2,912 
3,728 
3,748 
3,738 
3,204 
3,184 
1,469 
1,379 
1,008 
24,370 
Referred 
11 
40 
66 
62 
42 
54 
25 
25 
25 
350 
Percentage 
0 38 
1 07 
1 76 
1 66 
1 31 
1 70 
1 70 
1 81 
2 48 
Average 1 44 
1 496 of the women examined for the first time was referred to a 
surgeon for further investigation At the second examination this was 
0 8% and at the third examination 0 7% The large difference in the 
percentage of women referred during the 1st and 2nd examination is 
possibly caused by the fact that for the 2nd examination the old films 
were available for comparison Women were referred for further 
examination on radiological criteria only Mammography was the only 
used screening test 
Table 20 Referred for further investigation per age-group at 2nd examin-
ation Age at time of examination 
Age-gioup 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 + 
Total 
Second exam 
1,339 
3,155 
3,119 
3,152 
2,823 
2,568 
1,322 
861 
526 
18,865 
Referred 
7 
17 
34 
21 
21 
17 
18 
7 
7 
149 
Percentage 
0 52 
0 54 
109 
0 67 
0 74 
0 66 
136 
0 81 
133 
Average 0 79 
54 
Table 21. Referred for further investigation per age-group at 3rd. examin-
ation. Age at time of examination. 
Age-group 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 + 
Total 
Third exam. 
145 
2,443 
2,370 
2,325 
2,269 
1,795 
1,374 
-
-
12,721 
Re/erred 
I 
10 
17 
11 
23 
9 
13 
-
-
84 
Percentage 
0.69 
0.41 
0.72 
0.47 
1.01 
0.50 
0.95 
-
-
Average 0.66 
4.4. Number of biopsies after referral for further investigation 
Women with a lesion detected by mammography in the screening 
were referred to a surgical Out-patient Department at one of the hospi-
tals in Nijmegen by their general practitioner. 
In the Out-patient Department a detailed physical examination was 
done and a complete mammography serie was performed in the X-ray 
Department: the usual 2 views of each breast, if necessary with details, 
enlargement (Sickles 1980) and the axillary view. 
Table 22. Biopsies per age-group of women referred during the first examin-
ation. Age at time of examination. 
Age-group 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 + 
Total 
Examined 
once 
2,912 
3,728 
3,748 
3,738 
3,204 
3,184 
1,469 
1,379 
1,008 
24,370 
Biopsies 
7 
21 
49 
46 
32 
44 
19 
19 
19 
256 
Percentage 
0.24 
0.56 
1.31 
1.23 
1.00 
1.38 
1.29 
1.38 
1.88 
Average 1.05 
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• physical examination 
control after 6 months I ^ ^ anamnesis 
(mammography)-.^ 
к ^ - ^ Χ ^ 3 vieuws each breast 
over/projection M Mammography ^ ^ details 
1N ^ ^ ^ enlargement Group of 5 micro calcifications or more ^ 4 - * 
Suspect lesion suspect not suspect 
palpable not palpable 
echo" biopsy after к-ray 
" localisation 
/ 
solid control after 6 months 
(mammogrnphy) 
biopsy · 
benign -
malignant 
mastectomy or 
lumpectomy 
— • c o n t r o l after 6 months 
I mammography) 
Figure 1 3 Decision scheme of patients referred via general practit ioner to a surgeon 
because of suspected findings at the population screening. 
In palpable lesions ultrasonography was applied, followed by 
pneumocystography in case of a cyst (Muller 1980). 
In the hospital the following decision scheme was used (see figure 
13). 
The percentage of biopsies during the first examination was 196 and 
during the second- and third examination this was 0.5% of the women 
examined (see table 22, 23 and 24). Since biopsy of the breast has to 
be reckoned among the invasive diagnostic methods, it was tried to 
make its indication as sharp as possible. This requires a good co-oper­
ation between surgeon, radiologist and pathologist. In the hospital 
where 80% of the women were referred to, a 'diagnostic mamma-team' 
was therefore established. 
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Table 23. Biopsies per age-group of women referred during the second exam-
ination. Age at time of examination. 
Age-group Examined 
twice 
Biopsies Percentage 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 + 
1,339 
3,155 
3,119 
3,152 
2,823 
2,568 
1,322 
861 
526 
5 
9 
25 
13 
17 
16 
13 
7 
5 
Total 18,865 110 
0.37 
0.29 
0.80 
0.41 
0.60 
0.62 
0.98 
0.81 
0.95 
Average 0.58 
In this team, consisting of two surgeons, two radiologists and one 
pathologist, mammograms and clinical findings of the patients from 
the population screening program were discussed every week. The aim 
was to come to a correct diagnosis with methods as little invasive as 
possible. This way a lot of unnecessary biopsies were avoided in the 
past few years. 
Table 24. Biopsies per age-group of women referred during the third examin-
ation. Age at time of examination. 
Age-group Examined Biopsies 
3 times 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 + 
145 
2,443 
2,370 
2,325 
2,269 
1,795 
1,374 
-
-
0 
9 
15 
9 
18 
9 
8 
-
-
Total 12,721 68 
Percentage 
0 
0.37 
0.63 
0.39 
0.79 
0.50 
0.58 
Average 0.53 
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Table 25. Cancers found per age-group at the first examination. 
Age at time of examination. 
Age-group Examined 
once 
Cancers Percentage 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 + 
2,912 
3,728 
3,748 
3,738 
3,204 
3,184 
1,469 
1,379 
1,008 
1 
4 
19 
21 
16 
25 
9 
13 
18 
Total 24,370 126 
0.03 
0.11 
0.51 
0.56 
0.50 
0.79 
0.61 
0.94 
1.79 
Average 0.52 
Table 26. Cancers found per age-group at the second examination. 
Age at time of examination. 
Age-group Examined 
twice 
Cancers Percentage 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 + 
1,339 
3,155 
3,119 
3,152 
2,823 
2,568 
1,322 
861 
526 
0 
1 
8 
7 
9 
11 
10 
3 
3 
Total 18,865 52 
0 
0.03 
0.26 
0.22 
0.32 
0.43 
0.76 
0.35 
0.57 
Average 0.28 
Table 27. Cancers found per age-group at the third examination. 
Age at time of examination. 
Age-group 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75 + 
Total 
Examined 
3 times 
145 
2,443 
2,370 
2,325 
2,269 
1,795 
1,374 
-
-
12,721 
Cancers 
0 
1 
7 
3 
7 
6 
6 
-
-
30 
Percentage 
0 
0.04 
0.30 
0.13 
0.31 
0.33 
0.44 
-
-
Average 0.24 
4.5. Number of cancers found per age-group in the first-, 
second- and third screening 
In a population screening it is important to distinguish cancers found 
at the first examination, prevalent cancers, and cancers found at the 
following examinations, the incident cancers. 
The average detection rate in the population screening for breast 
cancer in Nijmegen was 5.2 per 1,000 examined in the 1st. investiga-
tion, in the 2nd. investigation 2.8 per 1,000 examined and in the 3rd. 
investigation 2.4 per 1,000 examined. 
The detection rate shown in table 25, 26 and 27, is strongly depen-
dent upon the age structure of the investigated group. In other words 
the more women of the older age-group were examined, the higher the 
detection rate. Among the 4,396 investigations by women under 40 
years of age only 1 cancer was found. This indicates that population 
screening has little effect for women in this age-group. 
In view of the high incidence of breast cancer in women over 
70 years of age it does not seem sensible to exclude them from the 
population screening, though on the other hand their participation is 
very low. It might be, however, that screening between 65 and 70 years 
will reduce cancer incidence over 70. For the present this is only a 
theoretical supposition. 
The predictive value of a positive test result was : 
36% in the first examination 
35% in the second examination 
36% in the third examination 
4.6. Tumor size and metastases 
Also in this aspect cancers found in the first investigation and in the 
second- and third investigation were distinguished. 
The size of the tumor was primary measured on the X-ray-film. 
Only if the measurement of the pathologist came out larger, the latter 
size was assumed to be more correct. In tumors over 1.5 cm in 
diameter there was hardly any difference between the size of the tumor 
on the X-ray and the size measured by the pathologist. Under 1.5 cm 
in size there were small differences because of measuring faults. If the 
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Table 28. Correlation of tumor size (mammographie) and nodal involvement, 
1st. examination. 
Size 
Microcalc. 
< 1 cm 
1-2 cm 
^ 2 cm 
Total 
Non mfìltr. 
carcinoma 
16 
-
-
-
16 
Infiltrating carcinomas 
Node neg. 
4 
3 
16 
5 
28 
Node pos. 
_ 
-
4 
12 
16 
Node not 
examined 
2 
3 
31 
30 
66 
Total 
22 
6 
51 
47 
126 
Table 29. Correlation of tumor size (mammographie) and nodal involvement, 
2nd. and 3rd. examination. 
Size 
Microcalc. 
< 1 cm 
1-2 cm 
> 2 cm 
Total 
Non ' mfiltr. 
carcinoma 
15 
-
-
1 
16 
Infiltrating carcinomas 
Node neg. 
5 
7 
14 
2 
28 
Node pos. 
1 
1 
3 
8 
13 
Node not 
examined 
3 
2 
14 
6 
25 
Total 
24 
10 
31 
17 
82 
X-ray film showed only microcalcifications (M.C.) the tumor size 
could not be measured, because the tumor was limited to the lumen 
of the ducts. 
In the 1st. investigation 28 of the 126 cancers were not invasive or 
smaller than 1 cm in size (minimal cancers), which is 22%. In the 2nd. 
and 3rd. investigation 35 of the 82 cancers, which is 43%, could be 
reckoned to be minimal cancers. 
4.7. Interval cancers and pseudo-interval cancers, sensitivity and 
specificity 
Interval cancers form a large frustration as well for those who carry out 
the population screening, as for those who are screened. 
An interval cancer is a tumor, found in the interval between two 
screenings, after a negative screening. Mostly an interval cancer is 
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found by the patient herself because of clinical symptoms. The interval 
time between two population screenings in Nijmegen is two years. The 
following number of interval cancers were found in the period 1975-
1980 (see table 30). 
Table 30 
1st. examination 
2nd. examination 
3rd. examination 
Total 
1. Interval cancers. 
Until I year 
after screening 
14 
11 
7 
32 
Until 2 years 
after screening 
21 
16 
37 
The follow-up from the third investigation is not yet complete. 
The interval ratio, which is the number of interval cancers per 1,000 
screened per year, was therefore: 
ι . • .· .·
 3 5
 ЬООО
 n
_ 0 1st. investigation χ = 0.72 
24,370 2 
τ A • •· . · 2 7 ЬООО - _ . 2nd. investigation χ = 0.72 
18,865 2 
3rd. investigation χ — = 0.60 
12,721 1 
The interval ratio in Nijmegen was reasonably constant in the three 
screening rounds at 0.7 per 1,000 examined per year. Assuming that 
an interval cancer discovered in the first year after screening has been 
missed by the screening, we can calculate the following sensitivity for 
the screening in Nijmegen : 
. . 126 
1st. investigation 
2nd. investigation 
3rd. investigation 
The average sensitivity from the three screening rounds was 87%. 
140 
52 
63 
30 
χ 10096 = 
χ 100% = 
χ 100% = 
 90% 
 83% 
= 81% 
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Calculating the specificity of the population screening, we find: 
1st. investigation — ! χ 100% = 99.1% 
24,230 
18 705 
2nd. investigation — χ 100% = 99.5% 
18,802 
3rd. investigation 1 2 , 6 3 0 χ 100% = 99.6% 
12,684 
(Galen and Cambino 1975.) 
Interval cancers merit special attention because they are a special 
group of tumors. We hoped to obtain information about wrong posi­
tioning and other factors. This knowledge might help to improve the 
quality of the screening. 
In collaboration with the pathologists R. Holland M.D. and 
M. Mravunac M.D., 64 interval cancers were revised radiologically and 
histologically. They were divided into four groups: 
1. Reporting mistakes by radiologist 19 
2. Incorrect technique and/or poor quality 4 
3. Radiologically occult tumor 21 
4. Not present at time of screening (fast growing), 
or too small 20 
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About 1/3 of the interval cancers are caused by technical faults (re­
porting and positioning), 1/3 is occult at the time of screening and 
1/3 are fast growing tumors (Holland et al. 1982). Pseudo-interval 
cancers in the Nijmegen investigation are cancers discovered more 
than two years after a negative screening. They are mainly the 
result of non participating in the last screening round. 
In total in the period 1975-1980 24 pseudo-interval cancers were 
discovered. 
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4.8. Histological classifications of breast cancers detected 
in the screening program 
The histological diagnoses were mainly made by the pathologists 
R. Holland, St. Radboud University Hospital and M. Mravunac, Cani-
sius-Wilhelmina Hospital (see table 31). 
Table 31. Histologic type of cancers detected by screening. 
1st. exam. 2nd. exam. 3rd. exam. 
Infiltrating cancer 
Ductal cancer 
Lobular cancer 
Tubular cancer 
Colloid cancer 
Medullary cancer 
92 
5 
7 
3 
3 
43 
3 
-
-
-
18 
1 
1 
-
-
Non infiltrating cancer 
Intraductal cancer 16 6 10 
Lobular cancer -
Total 126 52 30 
In general the histologic diagnosis of an invasive mammary cancer 
larger than 1 cm gives no problems. However, this can not be said for 
'minimal cancers' (Beahrs et al. 1979). For this reason all minimal 
cancers from Nijmegen were revised by two external pathologists. In 
100% of the cases the original histological diagnosis was confirmed. 
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Chapter 5 
DATA FROM THE BREAST CANCER REGISTRATION 
IN NIJMEGEN 1975-1980 
5.1. Introduction 
In view of the importance of a good cancer registration for evaluation 
of population screening, all primary breast cancers of women in 
Nijmegen were registered from 1-1-1975 onwards. The relevant infor-
mation was given by the Departments of Pathology, Surgery and 
Radiology of the Canisius-Wilhelmina Hospital and from the Depart-
ments of Pathology and Radiotherapy of the St. Radboud University 
Hospital. All information was brought together on a composite form 
(see for an example Appendix L). In order to allow computer pro-
cessing, the contents of these forms was transmitted on punch cards. 
The system was designed to guarantee a good follow-up for the follow-
ing years. 
5.2. Arrangement of cancers according to the way of detection 
In total 467 primary breast cancers were diagnosed in women in 
Nijmegen in the period 1-1-1975 until 31-12-1980. These patients can 
be divided into 4 groups, related to the population screening. 
1. The'non-participants': 166. 
This group has never participated in the population screening. A 
minor part of this group was never invited, because they were born 
after 1-1-1940 or during the first round, before 1-1-1910. 
2. The'interval'group: 69. 
The time between the diagnosis of the cancer and the last negative 
screening was at the most 2 years (interval time). 
3. The 'pseudo-interval' group: 24. 
The time between the diagnosis of the cancer and the last negative 
screening investigation was more than 2 years. 
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The 'screening' group 208 
Further divided in 
Pop Scr 1 (1st round population screening 1975-1976) 
Pop Scr 2 (2nd round population screening 1977-1978) 
Pop Scr 3 (3rd round population screening 1979-1980) 
Table 32 
Non-part 
166 
36% 
Year 
1975 
1976 
1977 
1978 
1979 
1980 
Total 
Int 1 
ps-mt 
93 
20% 
Non-P 
41 
30 
23 
23 
21 
28 
166 
Pop 
Scr 1 
77 
16% 
Table 33 
Int 1 
ps-mt 
- 1 
7 
21 
17 
22 
25 
93 
Pop 
Scr 
82 
2 
18% 
Year of diagnosis 
Pop 
SCr : 
33 
40 
2 
1 
1 
-
77 
Table 34 Distr ibution of patient-
Age-group 
30-34 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75-79 
80 + 
Non-P 
6 
10 
2 
9 
15 
11 
15 
23 
28 
23 
24 
Int 1 
ps-mt 
-
2 
13 
18 
19 
16 
9 
13 
2 
-
-
Pop 
Scr > 
— 
2 
4 
18 
20 
14 
19 
-
-
-
-
/ 
Pop 
Scr 2 
_ 
— 
34 
41 
7 
-
82 
groups over 
Ì 
Pop 
Scr 2 
_ 
1 
2 
9 
7 
9 
16 
13 
10 
8 
7 
Pop Total 
Scr 3 
49 467 
10% 100% 
Pop Total 
Scr 3 
75 
77 
80 
82 
15 66 
34 86 
49 467 
the age-groups 
Pop Total 
Scr 3 
6 
15 
1 22 
5 59 
6 67 
8 58 
9 68 
7 56 
6 46 
7 38 
31 
Total 166 93 77 82 49 467 
In table 32, 33 and 34 the interval and pseudo-interval cases are put 
together. 
As the attendance percentage in the older age-group was very low 
and the incidence of breast cancer rather high, most of the non-par-
ticipants with breast cancer belonged to this group. 
5.3. Reliability of mammography in the hospital 
To obtain an impression of the reliability of mammography of all these 
467 pathologically confirmed breast cancers, the findings of all pre-
operative mammographies were assembled (see table 35). 
Table 35. Radiological diagnoses. 
X-Ray 
finding 
Doubtful 
Suspect 
Normal, benign, 
mastopathy 
Unknown 
Malignant 
Total 
Non-P. 
3 
47 
6 
3 
107 
166 
Int./ 
ps-int. 
4 
34 
6 
-
49 
93 
Pop. 
Scr. 1 
21 
25 
-
-
31 
77 
Pop. 
Scr. 2 
11 
30 
-
-
41 
82 
Pop. 
Scr. 3 
9 
28 
-
-
12 
49 
Total 
48 
164 
12 
3 
240 
467 
In 12 (39a) of the 467 breast cancers no lesions were discovered at 
mammography. Also after revision of the X-ray films, these tumors 
were radiologically occult. In the group of 259 symptomatic patients 
(non-participants and interval/pseudo-interval) 12, i.e. 596, were 
radiologically occult. 
Dronkers (1979) came to a percentage of 4.1% of radiologically 
occult breast cancers. Especially in the hospital it is important to take 
into account the existence of these cancers. Every palpable tumor that 
can not be visualized by mammography is suspect for malignancy. 
5.4. Localization of the cancers 
In Nijmegen more tumors were localized in the right breast than in the 
left. This is in contradiction to what has been reported in the literature. 
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Table 36 Left-right localization 
Right 
Left 
Both 
Total 
Right 
Left 
Both 
240 = 
216 = 
11 = 
Non-P 
84 
77 
5 
166 
:514% 
:46 396 
: 2 496 
Int 1 
ps-mt 
46 
46 
1 
93 
Pop 
Scr 1 
41 
34 
2 
77 
Pop 
Scr 2 
47 
33 
2 
82 
Pop 
Scr 3 
22 
26 
1 
49 
Total 
240 
216 
11 
467 
In a series of 1,417 breast cancer patients from Tilburg, Arnhem and 
Leeuwarden, Beerepoot (1971) found 48 9% right sided and 511% left 
sided cancers 
Upper outer 
Upper inner 
Lower inner 
Lower outer 
Retr mamm 
Multi focal 
Total 
5 5 Tumor 
Table 37 
Non-P 
90 
14 
16 
18 
17 
11 
166 
size 
Int 1 
ps-mt 
45 
9 
9 
21 
7 
2 
93 
Quadrant localization 
Pop 
Scr 1 
48 
9 
10 
3 
7 
-
77 
Pop 
Scr 2 
50 
14 
5 
5 
8 
-
82 
Pop 
Scr 3 
27 
9 
3 
2 
8 
-
49 
Total 
260 
55 
43 
49 
47 
13 
467 
% 
56 
12 
9 
10 
10 
3 
100 
In case the diagnosis was made on microcalcifications only, the patient 
was included in the group 'smaller than 1 cm ' This was done because 
microcalcifications and tumors smaller than 1 cm form the so-
called 'minimal cancers' (Wanebo et al 1974) 
In symptomatic patients (non-participants, interval and pseudo-
interval) the average tumor size was 2 8 cm The average size of the 
screening cancers was half of this, 1 3 cm 
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Table 38. Tumor size in centimeters. 
Size 
Microcal/< 1 cm 
1-2 cm 
2-5 cm 
> 5 cm 
Total 
Non-P. 
22 
54 
66 
24 
166 
Int./ 
ps-mt. 
17 
38 
33 
5 
93 
Pop. 
Scr. 1 
27 
41 
9 
-
77 
Pop. 
Scr. 2 
22 
46 
14 
-
82 
Pop. 
Scr. 3 
30 
12 
7 
-
49 
Total 
118 
191 
129 
29 
467 
Number 
Minimal tui 
Maximal tu 
Table 39. 
•nor size 
mor size 
Average tumor size 
Average tumor size in 
Non-P. 
166 
1.0 
9.9 
3.1 
Int./ 
ps-mt. 
93 
0.5 
9.9 
2.6 
centimeters. 
Pop. 
Scr. 1 
77 
0.5 
3.5 
1.4 
Pop. 
Scr. 2 
82 
0.5 
4 0 
1.5 
Pop. 
Scr. 3 
49 
0.5 
5.0 
1.1 
Beerepoot (1971) found in his group ofMl? cancers an average size 
of 5 cm. Since in those years the size was estimated by palpation, we 
have to take 75% of this figure (Lundgren 1977). So the comparable size 
of that group was 3.7 cm. 
De Jong (1979) investigated the size of breast cancers in Leiden from 
1970 to 1976 and found an average diameter of 4.3 cm. For the year 
1975 this was 3.3 cm and for the year 1976 this was 3.7 cm. The tumors 
discovered at population screening in Leiden by palpation in 1975 
appeared to be slightly larger than those discovered outside the 
screening program (3.7 cm against 2.8 cm). 
Den Hoed-Sytsema et al. (1971) estimated the majority of mammary 
cancers to be between 3.5 cm and 5 cm. 
5.6. The axillary status 
As shown in table 40, the axillary status of 167 patients with breast 
cancer is not known. This concerns mainly older patients treated from 
1975 to 1979 in the Canisius-Wilhelmina Hospital by the McWhirther 
method. 
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Table 40. Lymph nodes. 
50 
44 
72 
30 
44 
19 
7 
55 
15 
8 
23 
51 
11 
28 
10 
106 
194 
167 
Nodes Non-P. Int./ Pop. Pop. Pop. Total 
ps-int. Scr. 1 Scr. 2 Scr. 3 
Positive 
Negative 
Not examined 
Total 166 93 77 82 49 467 
Table 40 shows clearly that a positive axilla is considerably less 
frequent in the patients from the screening than in symptomatic 
patients: 20% versus 48%. 
5.7. Mortality 
Information about mortality was collected from the Radiotherapy 
Departments of the St. Radboud University Hospital and the Canisius-
Wilhelmina Hospital, where almost all patients with breast cancer 
have had their regular check-ups. 
Table 41. Distribution of deceased patients of the different groups divided by 
age. 
Age-group 
30-34 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75-79 
80 + 
Total 
Non-P. 
2 
-
-
3 
5 
5 
1 
1 
7 
9 
11 
44 
Int./ 
ps-mt. 
— 
-
— 
4 
1 
2 
1 
-
— 
— 
-
8 
Pop. 
Scr. 1 
_ 
-
1 
3 
1 
1 
2 
-
— 
— 
-
8 
Pop. 
Scr. 2 
-
-
-
-
-
-
-
1 
2 
2 
2 
7 
Pop. 
Scr. 3 
— 
-
-
-
-
-
-
-
-
-
-
0 
Total 
2 
-
1 
10 
7 
8 
4 
2 
9 
11 
13 
67 
69 
Table 42. Year of detection in deceased patients. 
Year 
1975 
1976 
1977 
1978 
1979 
1980 
Total 
Non-P. 
16 
10 
7 
6 
3 
2 
44 
Int./ 
ps-int. 
-
1 
2 
3 
1 
1 
8 
Pop. 
Scr. 1 
5 
3 
-
-
-
-
8 
Pop. 
Scr. 2 
-
-
3 
4 
-
-
7 
Pop. 
Scr.3 
— 
-
-
-
-
-
0 
Total 
21 
14 
12 
13 
4 
3 
67 
Of 467 women with primary cancer discovered between 1975 and 
1980, 67 (14%) died of breast cancer in that period; 44 of these (66%) 
were from the group Non-Participants. 
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Chapter 6 
REVIEW OF THE RESULTS 
6.1. Introduction 
The direct results of the population screening for breast cancer indicate 
the great value of mammography for detecting breast cancer. With an 
average sensitivity of 87%, a specificity of 99%, and a predictive value of 
35%, mammography largely meets the requirements of a screening 
procedure. It is questionable if the high predictive value of 35% can be 
maintained in future. Thanks to the development of better X-ray 
equipment, which enables us to make sharper pictures and enlarge-
ments, we demonstrate more questionable findings. Especially groups 
of microcalcifications are a difficult problem. A lot of investigation is 
still required in order to come to better differentiation between malig-
nant and benign calcifications. If our knowledge does not keep pace 
with the progress of the technique, the number of negative biopsies 
will rise to unacceptable heights (Lányi 1982). 
The results of the population screening in Nijmegen in the age-group 
of 35 and above were 5.2 cancers per 1,000 women in the first-, 2.8 
cancers per 1,000 women in the second- and 2.4 cancers per 1,000 
women in the third round. This is comparable to investigations in 
Sweden and the United States of America, where the same age-group 
has been screened (see table 44, pp. 76/77). In the age-group of 50-65 
years 6.1 cancers per 1,000 women were found in the first round, 3.2 in 
the second, 2.5 in the third. 
The interval cancers, 0.7 per 1,000 women per year, are a serious 
problem. It is possible that the interval time in Nijmegen (2 years 
between every screening) is too long for the age-group under 60 years 
of age. A further investigation of the growth rate of breast cancers, 
correlated to age, will shortly provide us with more information. 
It is encouraging that in the first round 22% minimal cancers were 
discovered and 43% in the second- and third round. Also the fact that 
the average diameter of the tumors found in the screening was 1.3 cm 
71 
and decreased to 1.1 cm in the third round, - compared to the 2.8 cm 
of the tumors found outside the screening - , supports the opinion that 
breast cancer can be discovered in an earlier phase by screening. For 
an estimation of this gain in time, please see the calculation of the lead 
time (6.3.). First of all we will check if the population screening in 
Nijmegen meets with the criteria from Wilson and Jungner. 
6.2. Comparison with Wilson and Jungner's criteria 
1. That breast cancer is an important health problem in the Nether-
lands, needs no further discussion. 
2. There has to be a generally accepted treatment. Accepted treatment 
for breast cancer means, to achieve a relatively high survival rate after 
the 5 or 10 years follow-up period. 
Presently there are some alternatives to fulfil this requirement. For 
tumors > 2 cm the Halsted radical mastectomy, the Patey modified 
radical mastectomy and the simple mastectomy is widely used. There 
is no significant difference among these three methods in survival rate 
(Henderson and Canellos 1980). Less information can be obtained 
however about the extension of the disease in the last method, due to 
the lack of lymph node dissection. 
For tumors < 2 cm - included pre-invasive cancers as well - , a less 
mutilating method has been introduced a few years ago in some insti-
tutions. This means a quadrantectomy or lumpectomy with axillary 
node dissection followed by radiotherapy (Veronezi et al. 1981). A 
thorough follow-up is needed to evaluate the effect of this method on 
local recurrence, as multifocality could be an important obstacle for 
this method (Rosen et al. 1975, Shah et al. 1973). Up to now there are 
very few studies dealing with the multifocality of small breast cancers, 
^ 2 cm (Morgenstern et al. 1975). 
AU these surgical and/or radiotherapeutical methods fulfil the 
requirements mentioned above. 
3. Concerning the possibilities for further diagnosis and treatment, 
the situation in Nijmegen was ideal. Both hospitals had the most 
modern mammography equipment and also had a wide experience in 
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biopsy of non palpable lesions. In spite of the fact that the localization 
of the tumor was known from the mammogram, more than 50% of the 
tumors found at the population screening were not palpable and had 
to be removed after X-ray localization (Frank 1976). 
This last technique also requires a close co-operation between radi-
ologist, surgeon and pathologist. 
4/5. Until now mammography is the only way to detect breast cancer 
in a preclinical stage. Also its sensitivity, specificity and predictive 
value meet the requirements for a population screening. Furthermore 
the risk from ionizing radiation is negligible. 
6. That our investigation method is acceptable for the population, is 
most clearly shown by the high attendance also in the second- and 
third round of the screening. 
7. Unfortunately, there is not enough known about the development 
of breast cancer, so this condition can not be fulfilled. However the 
population screening has learned us already a lot about the early phases 
of breast cancer. 
8. The answer to the question who is to be treated as a patient, is in 
the hands of the pathologist: Is the lesion detected a cancer or not? 
Of course the diagnosis of so-called minimal cancers is more diffi-
cult than of tumors of 3 cm in diameter for the pathologist. That is why 
in Nijmegen a number of securities are built in. In case of a minimal 
cancer the pathologists normally do not apply the frozen section tech-
nique. In their opinion paraffin coupes are necessary for a definite diag-
nosis. Furthermore the preparations are always evaluated by two 
pathologists. For extra security in the evaluation of our material the 
minimal cancers were subjected finally to the judgement of an external 
pathologist. 
9. Finding 1 cancer costs ƒ 10,000.-. This equals the cost of 25 days 
hospitalization per case. Therefore from medical economical point of 
view it does not seem very economical. This however is not a normal 
criterion in medicine. In many cases a tremendous amount of money 
is spent to prolong a life, even if the consequence is not a very 
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enjoyable life. For the women saved from metastases it does not only 
mean survival, but also survival in a normal good condition. Apart 
from that, the early detection often allows lumpectomy instead of 
radical mastectomy. 
The cost can also be expressed per year per number of the total popu-
lation. In fact without research it can be done for ƒ 2.- per person per 
year. 
10. The continuation of the population screening in Nijmegen is 
assured for the fourth round. If this will be possible after 1982 depends 
on the funds available, which again is largely influenced by political 
factors. 
6.3. Estimation of the lead time 
The lead time is the number of months or years the diagnosis is made 
earlier due to screening. The longer the lead time the greater the 
chance that the screening has a positive effect on the survival rate of 
breast cancer. 
Several authors have tried to make a calculation of the lead time. 
The first one was Zelen (1969, 1976). 
He gave the following formula for its calculation. 
L= 1/2 m (1 +c2) 
L = the average lead time 
m = length of time in screening phase = prevalence divided by inci-
dence. 
с = variable factor for the length of stay in the screening phase. 
Later on Lundgren (1977) gave a simpler formula: 
L = X · DT 
L = average lead time 
X = average number of doublings needed to come from the average 
volume in screening to the average clinical volume. 
DT = average doubling time. 
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The last formula seemed easier to apply, especially because in co-
operation with the epidemiologist B. V. Bekker M.D. the average 
volume-doubling time of a number of screening and interval cancers 
could be calculated. 
The volume-doubling time of 35 cancers could be calculated out of 
two measurements, one related to tumor diameter on X-rays, and the 
other related to the interval between the two X-ray examinations. Of 
these 35 cancers 18 were screening cancers and 17 were interval 
cancers. 
Table 43. Doubling time, range and median. 
DT average Range Median 
18 screening cancers 426 days 98-960 days 372 days 
17 interval cancers 190 days 60-434 days 152 days 
35 cancers 312 days 60-960 days 299 days 
Table 43 clearly shows that screening causes a selection because the 
slow growing tumors have more chance to be detected in the screening 
(length-biased sampling). 
In literature several doubling times for primary breast cancers are 
given by different authors. 
DT average Range DT 
Lundgren 1977 211 days 42-379 days 
Spratt 1977 117 days 87-147 days 
Heuser 1979 325 days 109-944 days 
Nijmegen 312 days 60-960 days 
Furthermore, according to Lundgren, the average number of volume 
doublings needed to come from the screening diagnosis to the clinical 
diagnosis is important for the calculation of the lead time. 
For this we have some important data. The average diameter of the 
tumors found at the screening was 1.3 cm, the average diameter of the 
tumors found in symptomatic patients was 2.8 cm. 
A growth from 1.3 cm to 2.8 cm means an increase in diameter with 
a factor of 2.2 but in volume with a factor of 10. For this increase in 
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Table 
Method of 
investigation 
Start of 
investigation 
Number of rounds 
H.I. P. 
U.S.A. 
Randomized 
controlled trial 
1963 
4 rounds 
B.C.D.D. P. 
U.S.A. 
Volontary 
participation 
1973 
5 rounds 
Malmö 
Sweden 
Randomized 
controlled trial 
1977 
? 
Age-group 45-64 years 35-74 years 45-69 years 
Interval between 
2 investigations 
Detection method 
Attendance 
1st. round 
1 year 
palpation 
mammography 
2 views 
20,166 (65%) 
1 year 
palpation 
mammography 
2 views 
280,000 
0 
mammography 
2 views 
15,748 (74%) 
Sensitivity 75-95% 1st. round 85% 91.5% 
2nd. round 77% 
Specificity 99% - 97.4% 
Predictive value - - 22.3-47.2% 
Detection rate 
1st. round 
Interval cancer 
rate/year 
2.73/10' 
0.65/103 
5.59/IO1 
1.0/103 
7.4/10' 
0.7/10' 
Results: 
Percentage minimal 
cancers 12% (4 rounds) 28% 59% (1st. round) 
(1st. + 2nd. round) 
Reduction mortality 30% not yet available not yet available 
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Kopparberg D.O.M., Utrecht Leiden Nijmegen 
Sweden The Netherlands The Netherlands The Netherlands 
Randomized 
controlled trial Whole population Whole population Whole population 
1977 1974 1975 1975 
2 rounds 4 rounds 1 round 4 rounds 
> 39 years 50-64 years ^ 35 years 35-65 years 
Isl. round 
> 35 years 
2nd. + 3rd. round. 
2 1/2 years 
mammography 
1 view 
34,187 (84%) 
1,1 1/2 and 2 years 
palpation 
mammography 
2 views 
14,697 (72%) 
palpation 
15,971 (69%) 
2 years 
mammography 
1 view 
24,370 (69%) 
95.5% 96% ? 87% 
98.9% 99% ? 99% 
14-38% 42% 1.7% 35% 
6.9/103 
0.3/10' 
7.6/10' 
0.3/10' 
2.6/10' 
9 
5.2/10' 
0.7/10' 
1% (1st. round) 26% (1 round) 0% 22% (1st. round) 
43% (2nd. + 3rd. 
round) 
ot yet available not yet available not yet available not yet available 
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Table 45. 
Factor with which Needed doublings 
the diameter of the for this 
tumor increases 
1.1 
1.25 
1.6 
2 
2.5 
3.2 
4 
5 
6.4 
8 
10 
0.5 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
volume approximately 3.5 doublings are necessary. See table 45 ac­
cording to Bekker. 
Now it is possible to calculate the lead time for the population 
screening in Nijmegen with the Lundgren formula: L = X · DT 
L = 3.5 χ 312 days = 1092 days = 3 years. 
Lundgren found an average lead time of 3 years in Sweden as well. The 
average lead time in the H.I.P. study in New York was 1.5 years. 
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Chapter 7 
CONCLUSIONS AND RECOMMENDATIONS 
7.1. Conclusions 
The results of the population screening for breast cancer in Nijmegen 
clearly show that mammography meets the high demands which have 
to be made on a screening. With our method of mammographie 
screening a high sensitivity and specificity and a high predictive value 
are reached. Also the detection rate of tumors, the stage in which they 
are detected and the long lead time make us optimistic about the ulti-
mate aim, the reduction of the mortality from breast cancer. In the 
H.I.P. study a reduction of the mortality of 30% was reached with half 
the detection rate of cancers and half the lead time. 
Towards the application of mammography on a large scale e.g. a 
nation-wide population screening, we are very pessimistic however. 
The main problem is the quality of the mammographie technique and 
the reporting quality. In 1981 Zwaveling wrote in his book 'Kliniek van 
Mammatumoren' that mammography fails in diagnosing cancer in 
2096 of the symptomatic cases. In case this would not be based on a 
local very limited situation only, but would apply for most X-ray 
Departments in the country (what we do not believe), this would mean 
that both radiologists and radiographers in the Netherlands need a 
thorough post-graduate training, before a nation-wide population 
screening can be started. Anyway the demands of a population 
screening are higher than those in the hospital and therefore we feel 
a special training and testing is required for all radiologists and radi-
ographers performing population screening. 
7.2. Recommendations for future research 
Further research is required into the value of the enlargement 
mammography. Can microcalcifications be better differentiated with 
79 
the enlargement technique? Studies of the correlation between the 
radiological and histological images are necessary to obtain a deeper 
understanding of the meaning of the character and division of micro-
calcifications in benign and malignant processes of the breast. The so-
called radiologically occult breast cancers need closer investigation. 
The value of ultrasound for diagnosing these tumors has to be inves-
tigated. 
Now that more and more breast cancers are detected with screening 
in an earlier stage it is important that pathologists find out more about 
the early stages of breast cancer. We hope that this will learn us more 
about the origin of mammary cancer. More investigation into multi-
focality of various types of breast cancers is necessary, especially in 
view of breast saving surgery. 
7.3. Possibilities for large scale screening 
If we want to improve the prognosis of breast cancer in the next few 
years, a large scale population screening with mammography is the 
only possibility. Because more investigations, training and post-
graduate teaching will be necessary before we can even think of a 
national population screening for breast cancer, it is now the correct 
time to start the organization. Waiting until the population screening 
programs which are now in progress, have proved a decrease in the 
mortality of breast cancer in the screened population group, is asking 
for chaos. The high probability of a considerably improved survival 
rate requires that the preparations for a national screening ought to be 
started already now. 
If we assume that the female population of the Netherlands of 
40 years and older is going to be screened for breast cancer every two 
years and that there will be an attendance rate of 70%, approximately 
1,000,000 women have to be examined every year. The capacity of one 
mammography unit is approximately 10,000 examinations per year. 
This way we would need about 100 mammography units and 400 
specialized radiographers. 
In organizing such a population screening, we have to deal with two 
important factors, which are very closely related : 
1. the quality of the examination in the screening center; 
2. the quality of the treatment in the hospital. 
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The danger of overtreatment connected with population screening 
should be well realized. 
The quality of the examination in the screening center has to be 
optimal. This applies to the X-ray- and development equipment as 
well as to the knowledge and positioning technique of the radio-
graphers. 
The ability of the radiologist to distinguish between normal and 
benign on the one hand and suspect for malignancy on the other hand 
is of great importance. 
An optimal quality is required in the hospital as well, where the 
lesions detected have to be further diagnosed and treated. 
Here the high quality concerns especially: 
- Radiodiagnosis: correct localization of non palpable lesions in the 
breast. 
- Surgery: biopsy and further treatment of non palpable breast 
cancers. 
- Pathology: diagnosis and classification of so-called minimal 
cancers. 
The quality on all these levels is an important condition for an effective 
population screening on breast cancer. It therefore has to be checked 
regularly. 
Overtreatment is one of the main risks of a population screening 
(Sturmans 1978). Overtreatment is closely connected with the quality 
of the investigation in the screening center and in the hospital. It can 
largely be avoided by regular consultations between the specialists 
involved in the screening and the specialists involved in the diagnosis 
and treatment of the referred patients. 
This consultation preferably has to be structured in a diagnostic 
team. On this team should be: the radiologist responsible for the 
screening, the hospital-based radiologist, the pathologist and the 
surgeon responsible for further diagnosis and treatment. Such a team 
that meets regularly, lays down the policy with regard to further diag-
nosis and treatment of the women sent from the screening center. 
Only this way a high predictive value of a screening program can be 
attained and many unnecessary biopsies avoided. At the same time the 
feed-back from the hospital to the screening center and the follow-up 
of the referred women are facilitated. 
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The organization of a nation-wide population screening for breast 
cancer could be set up as follows : 
rAUTHORITYl 
/ 7 \ X REGIONAL CENTRE5I ( integrated cancer centres) 
ISCREENING CENTRESl 
The authority: On this authority the government, the national health 
and the regional centers should be represented. Its most important task 
is quality insurance and evaluation of the screening. Members of such 
a committee should be also: an epidemiologist, a radiologist, a 
surgeon, a pathologist and a physicist. 
Regularly all screening centers should be checked for: 
- the quality (sharpness and density) of the films; 
- the radiation dose required ; 
- the predictive value; 
- the numbers of screening cancers and interval cancers; 
- the quality of the histology. 
Also a good cancer registration is of course a primary demand. The 
pathological diagnosis of the so-called minimal cancers has to be 
chequed by an external pathologist. 
Regional centers: These centers could be incorporated in the existing 
integral cancer centers. Here not only the screening and interval 
cancers, but also the breast cancers detected outside the screening are 
registered. Also the mortality from breast cancer is accurately regis-
tered. 
As far as breast cancer screening is concerned at least an epidemi-
ologist and a radiologist should be incorporated. The radiologist should 
be made responsible for the quality of mammography and the training 
of the radiographers in the various screening centers in the region. 
At the same time he/she should take care of the reporting and 
referral of the women via their general practitioners to the hospitals. 
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If possible he/she should participate in the diagnostic teams of the 
region. 
The screening centers: These are the centers where the actual screening 
takes place. This type of center can be situated in any place e.g. in a 
community health center. In view of the specific problems connected 
with X-ray equipment, processors, quality control and radiation dose 
it seems sensible to situate screening centers near an existing X-ray 
Department or manage them as a separate part of it. This would not 
only have a favourable influence on the quality but it would save 
money as well. Because of the chance of technical trouble, every 
center should have at its disposal at least two mammography units. 
In the major cities several centers should be spread over the area. 
For the time being, the use of a mobile unit is not advisable because 
of the sensitivity of the X-ray- and development equipment. In smaller 
towns it could be considered if the overcapacity of the existing hospital 
X-ray Departments could be used. It should be made possible that e.g. 
time is reserved for symptomatic patients in the morning and for 
screening in the afternoon. Of course, in this situation a good control 
of the quality by the regional center is necessary. 
The crew of the screening center with a capacity of 10,000 exam-
inations a year, should have 4 full time radiographers and one clerk. 
Apart from the actual examination the radiographers will be able 
to make a pre-selection of the X-ray films into the absolute normals 
(± 9096) and the ones that require radiologists reporting (± 10%). 
Quality demands which have to be made on radiologists: He/she has 
to have special knowledge of mammography, epidemiology, radiation 
dose, and the consequences of early diagnosis. He/she is responsible 
for the quality of the mammography technique in the screening 
centers that fall under his/her supervision. 
He/she has to report on the examinations selected by the radiogra-
phers, and has to take care of the report to the general practitioners 
and the surgeons. At random he/she tests the performance of the 
radiographers in the selection of normals and abnormals. Further 
more he/she participates in the various diagnostic teams. 
At the same time he/she must take care of the feed-back and follow-
up from the hospital to the regional center. 
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Quality demands which have to be made on the radiographers: Fully 
qualified radiographers are necessary. They have to have special 
knowledge of mammography and its difficult positioning technique. 
They also have to be trained in palpation of the breast. They have 
to have a more extensive knowledge of breast pathology than the 
average radiographer, in order to be able to make the pre-selection of 
the films to be reported by the radiologist. For this an intensive train-
ing in one of the existing centers seems to be necessary. 
Regular post-graduate training is an obligation both for the radi-
ologist and the radiographers employed in a screening center. 
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Bevolkingsondel zoek op borstkanker 
door middel van mammografìe 
in Nijmegen 1975-1980. 
SAMENVATTING 
Borstkanker is in Nederland een belangrijk gezondheidsprobleem. Eén 
op de veertien vrouwen krijgt in de loop van haar leven borstkanker. 
Ondanks alle moderne behandelingsmethoden sterft iets meer dan de 
helft van de vrouwen bij wie borstkanker wordt ontdekt aan deze 
ziekte. De sterfte aan borstkanker is op dit moment alleen terug te 
dringen door ontdekking ervan in een vroeger stadium. 
Met behulp van een optimale mammografietechniek is de radiodiag-
nost in staat deze vroege stadia van borstkanker op de röntgenfoto aan 
te tonen. In het algemeen geeft borstkanker in vroege stadia geen 
klachten en is de tumor meestal niet met de hand te voelen. 
Vandaar dat zowel in Nederland als in het buitenland de verwach-
tingen hoog gespannen zijn om door middel van mammografisch 
bevolkingsonderzoek de sterfte aan borstkanker te kunnen reduceren. 
In hoofdstuk 1 wordt nagegaan op welke wijze door middel van 
bevolkingsonderzoek de sterfte t.g.v. borstkanker kan worden terug 
gedrongen, tevens worden de voorwaarden genoemd waaraan een 
dergelijk onderzoek dient te voldoen. 
In hoofdstuk 2 worden de begrippen sensitiviteit, specificiteit en 
voorspellende waarde omschreven, met behulp waarvan de kwaliteit 
en de resultaten van een bevolkingsonderzoek kunnen worden beoor-
deeld. De resultaten van een aantal bevolkingsonderzoeken op borst-
kanker in de Verenigde Staten, Zweden en Nederland worden op een 
rij gezet. 
In hoofdstuk 3 wordt de organisatie en de administratieve gang van 
zaken bij het bevolkingsonderzoek op borstkanker te Nijmegen behan-
deld. Uitgebreid wordt er ingegaan op de röntgentechniek bij het 
bevolkingsonderzoek, waarbij ook de stralenbelasting en het risico van 
de mammografie ter sprake komen. Grote nadruk wordt gelegd op de 
epidemiologische begeleiding van het bevolkingsonderzoek. Vervol-
gens wordt een overzicht gegeven van het voorkomen en de sterfte 
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t.g.v. borstkanker in Nijmegen en Arnhem in de jaren 1970-1974, 
voorafgaande aan het bevolkingsonderzoek. 
In hoofdstuk 4 worden de resultaten gegeven van het bevolkingson-
derzoek op borstkanker te Nijmegen over de jaren 1975 tot en met 
1980. 
In hoofdstuk 5 worden de borstkankers, gevonden bij het bevol-
kingsonderzoek, vergeleken met de tumoren die in dezelfde periode 
buiten dit onderzoek werden ontdekt. Deze vergelijking werd mogelijk 
door de registratie van alle borstkankers die sinds 1 januari 1975 bij 
vrouwen uit de stad Nijmegen werden ontdekt. 
In hoofdstuk 6 wordt nagegaan of het bevolkingsonderzoek op 
borstkanker in Nijmegen heeft voldaan aan de voorwaarden die in 
hoofdstuk 1 werden gesteld. Tevens wordt aan de hand van de verdub-
belingstijden van de gevonden tumoren de 'lead time' berekend. Dit 
is de tijd dat de tumor ten gevolge van het bevolkingsonderzoek eerder 
wordt ontdekt. 
In hoofdstuk 7 wordt de conclusie getrokken dat bevolkingsonder-
zoek door middel van mammografie het mogelijk maakt borstkanker 
in een vroeger stadium te ontdekken. Hierdoor zal de sterfte aan borst-
kanker de komende jaren gaan dalen. Tevens worden aanbevelingen 
gedaan voor bevolkingsonderzoek naar borstkanker op grote schaal. 
Belangrijke voorwaarden hiervoor zijn, een goede kankerregistratie en 
een goede kwaliteitsbewaking zowel in de screeningscentra als in de 
ziekenhuizen waar verder onderzoek en behandeling moet plaats 
vinden. 
86 
Appendix A 
Oproep onderzoek 
Borstkanker 
U wordt uitgenodigd 
te 
aanwezig te zijn tn hel gebouw van de 
Gemeentelijke Geneeskundige- en Gezond­
heidsdienst, Nijmegen, ingang Trajanusplein 
(onderverdieping}, 
het Gemeentebestuur 
GEMEENTE NIJMEGEN 
bureau bevolking 
Aan Mevr/Mej. 
Deze oproep meebrengen! 
De kosten aan dit onderzoek verbonden, zijn op deze 
kaart links boven vermeld. 
Verzoeke met gepast geld te betalen. 
Zie ommezijde. 
tngang onderverdieping linksvan de hoofdingang GG en GD 
Ρ • Parkeren 
Het gebouw van de G G en G D te bereiken met stadsbus 
Lijn 1 vanaf Grootstad haîte Marienburg Hertogplein 
1 vanaf Hengstdal halte ν d Brugghenstraat, Hertogpiem 
2 beide richtingen ha te Burchtstraat 
3 vanaf Waterkwartrer hate Manenburg/Hertogpiein 
3 vanaf Brakkenstein : h a . t e v d Brugghenstraat Hertogpiem 
4 beide richtingen hate Plein 1944* 
5 vana* Berg en Dal ha te Berg en Dalseweg Manaplem 
5 vanaf Dukenburg halte Vir Franckenstraat 
8 beide r chtingen halte Plein 1944" 
* overstap moge lijk he id op lijn 1 of 3 
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1 T I T E L : W U K - E N B U U R T I N D E U N G O N D E R W E R P 
D o c u m e n t a t i e 
OOBeriBdemtad 
Ol CentAim 
02 Bot'ende»! 
03 Gstganveid 
04 Altrade 
05 Hunnerberg 
06 Hengitdal 
07 KwBkkenbwg 
09 Ooyso Sci irperdom 
N i j m e g a n - Z u i d 
10 Ni]e Veld 
11 HazenVemp 
12 GoftBft 
13 St Anna 
14 HaterUeHei 
1b Grootsl t l 
16 Hatert 
17Heyen(ls»1 
18 Brakkrnstem 
Nijmegen • West 
20 B'titn 
21 Wolfekull 
22 Hees 
23 Meseweld 
24 Neerbowh 
25 Haven- en 
indus irte terre ι η 
D u k e n b u r g 
31 To lhut i 
32 Zw »η en veld 
33 Me.ihorsi 
34 Lankforsl 
35AltJenhof 
36 Malvert 
37 Weeíenhof 
38 Vooelíang 
39 Stadd.ik 
Lindenholt 
40 LbttenhPlt 
GEMEENTE NIJMEGEN 
FMJBLIEKE WEBKEN EN VOLKSHUISVESTING 
AANVULL ING D D . 
VERVANGING D D : 
JAAR; 1974 
BLAD: 1 
HOOFDSTUK 0 
PAHAGHAAF: 3 1 
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__ŒVOU0NCSONOeRZOB<_ 
BORSTKANKER 
NIABGEN 
Nijmegen, 
Geachte Mevrouw, 
Enige ti]d geleden werd u een oproep toegezonden om deel 
te nemen aan het bevolkingsonderzoek op borstkanker. Tot 
onze spijt bent u na die oproep niet naar het onderzoek-
centrum gekomen. 
Wi] hebben voor u een nieuw tijdstip gereserveerd waarop 
u zich kunt laten onderzoeken en wel op 
om uur. 
Mocht dit tijdstip u niet schikken, laat u ons dit even 
weten. Wij kunnen dan een andere afspraak met u maken. Het 
onderzoek vindt plaats in het gebouw van de Gemeentelijke 
Geneeskundige en Gezondheidsdienst, Sint Jonsstraat 72, 
Nijmegen (ingang aan het Trajanusplein). 
Mocht u niet willen deelnemen, dan verzoeken wij u onder-
staand formulier in de bijgevoegde eveloppe (postzegel is 
niet nodig) aan ons te zenden. 
Hoogachtend, 
Drs^ j^ H^ cri.^  НепаГ1кз
А
 radioloog 
Wilt u dit formulier per omgaande inzenden als u niet 
kunt of wilt deelnemen aan het bevolkingsonderzoek naar 
borstkanker. 
Wilt u aankruisen waarom u niet meedoet: 
Q er zijn minder dan een half jaar geleden röntgenfoto's 
van de borsten (mammografie) gemaakt 
| | ik heb geen interesse 
| | andere reden, namelijk: 
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о 
> 
TD 
χ: 
о 3 Q. 
χ ' 
α 
FT 'УЩ 'Ό'»"ö¡ί)~> njn ц ιι »J?!"'. g » i;|lín | f é l f . ~»|<ПГ»Tiij«;» я V;^ i я Йу|« я»нсрТпЩ?."·^^ 'іГііі| i 
ππη 
! 
2 2 2 2 
3 3 3 3 
4 4 4 4 
5 5 5 5 
fi-6 6 6 
7 7 7 ? 
? > « 
S S 9 
ΠΠΠΠ 
5 10 Η Ι! 
Π Ι 1 
22 2 
3333 
4444 
S555 
866 
77 77 
1 1 ) 
22 2 
3333 
44 ; 
5 5 5 5 
6 6 6 6 
77 7 7 
Ι li« 
9999 
ι« Ч го 
1 I 
222 
333 
444 
55 
666 
7 7 7 
.η н η г« 
M 1 J 
2222 
зз з 
4444 
5 55 
666 
? 77 
ОТО 
я й ir я 
1 1 1 
2 2 2 2 
3 3 3 3 
4 4 4 
5 5 5 5 
8866 
7777 
en 
»и 
s; J3 
1 1 
2222 
3333 
44 44 
555 
8666 
777 7 
9 9 9І1 
8 6 6 8 8 8 
! ;• н|,»)9 л J) 
Э9І39 9 9 
22 
3333 
4 4 4 4 
55 
6666 
7 77 7 
2222 
3333 
4444 
5555 
6666 
7777 
2222 
3333 
4444 
5555 
6686 
7777 
2222 
33 33 
4 444 
5555 
66 66 
77 77 
»3« И36НЗ«М«'Ч!*!" 
9 9 9 8 9 9 3 9 9 9 9 9 9 99 3 9 3 9 4 
2 2 2 2 
3333 
444 4 
5555 
6666 
7 7 7? 
rm 
si и si s« 
i n i 
2 2 2 2 
3 3 3 3 
4 4 4 4 
5 5 5 5 
8 6 6 8 
7 7 7? 
HMS9 6J 
1 1 1 
2 2 2 2 
3333 
4444 
5555 
8866 
7 7 7? 
J Sí » Я 5? S8 Я «i 
J 9 9 9 9 9 9 9 
2222 
3333 
4 4 4 4 
5555 
6666 
7 77? 
2222 
3333 
444 4 
5555 
6666 
777 7 
2 2 2 2 
3333 
444 4 
5 5 5 5 
666 
7 ? ? ? 
si и w Ufi »s v »«s -о « »г η « ι» « >' η 
9999 9 9 9 9 9 9 9 9 3 9 9 9 3 I 
2222 
3333 
44 4 
5555 
8666 
1 77 
2 222 
3 3 3 3 
4 4 4 4 
5 5 5 5 
8 6 6 6 
? 7 ? 
» M A 9000 
Appendix E 1 
b j eeVOLKINGSONOERZOEK BORSTKANKER NIJMEGEN 
VRAGENLIJST 
Volgnummer 
Geboortedatum 
Onderzoekdatum 
Ai 
DEZE GEGEVENS BLIJVEN GEHEIM 
In te vullen door de laborante lengte gewicht 
22л22 
Doorstrepen wat niet van toepassing Is 
Waar nodig Invullen 
Bent U een vrouw ja/je^ 
Wanneer eindigde de tweede wereldoorlog 19 ¿iS 
HUIDIGt KLACHTEN 
Pijn in borst _ _ 
Vocht uit tepel _ 
Knobbel In borst _ 
Knobbel in oksel _ 
Letsel borst door val of ongeluk 
Huidverandering van borst 
Ouur van klachten _ _ weken/maanden/jaren 
Onderzoekt U zelf de borsten regelmatig 
LINKS 
Ja/nee 
ja/nee 
Ja/nee 
ja/nee 
ja/nee 
ja/nee 
RECHTS 
Ja/nee 
Ja/nee 
3a/nee 
Ja/nee 
Ja/nee 
Ja/nee 
30.36 1>-4 
ja/nee Ja/nee 
VROEGERE KLACHTFN, BEHANDELING OF OPERATIE VAN DE BORST 
Heeft U ooit een ontsteking van de borst gehad 
Heeft U een insnijding tn de borst gehad bi 1 ontsteking. 
Is er vocht uit Uw borst geprikt 
Heeft U гоет letsel van de borst gehad 
Heeft U bestraling van de borst gehad 
Heeft U сен oocratie voor verkleining van de borst gehad __ -
Heeft U een operatie voor vergroting van de borst gehad(prothese) -ja/noe 
Heeft U een andere operatic aan de borst gehad _ _ 
LINKS 
ja/nee 
ja/nee 
]a/nee 
ja/nee 
ja/nee 
ja/nee 
Ta/ne
ja/nee 
RECHTS 47-^ 4 
ja/nee 
ja/ne* 
ja/nee 
ja/nee 
ia/nee 
]a/nee 
]a/nee 
ja/nee 
*5-tó 
GbBOORTb 
Aantal levend geboren kinderen 
Aantal miskramen of doodgeboren kinderen _ 
Geboortejaar eerste kind (levend of doodgeboren) — 
Geboortejaar laatste kind (levend oF doodgeboren)-
Bent U het afgelopen half jaar zwanger geweest 
Heeft U kinderen met aangeboren lichamelijke of 
geestelijke afwijkingen (b.v klompvoetje, mongooltje)^ 
19 _ 
19 
ja/nee 
« 3 ^ 
67.É8 
69-70 
71 
ja/nee 
BORSTVOEDING 
Hoeveel kinderen heeft U zelf borstvoeding gegeven 
Geeft U op het ogenblik borstvoeding _ 
Heeft U het afgelopen half jaar borstvoeding gegeven. 
— ja/nee 
ja/nee 
73-74 
'S 
76 
CA VEROER OP BLAD, A2 
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MENSTRUATIE 
Leeftijd eerste menstruatie — 
Is/was de menstruatie qcwoonlijk regelmatii) 
Om de hoeveel weken heeft/had U de menstruatie 
Duur van de menstruatie _ 
Bloedverlies tijdens de menstruatie _ 
Gespannen gevoel of Dijn In borst vóór menstruatie 
Datum laatste menstruatie. 
— _ 24-2!) 
-ja/nee 26 
- _ weken 27-2ö 
— dagen 29-Э0 
weinig/normaal/veel 31 
Ja/nee Э? 
— зз-эь 
А 
OVERGANG 
Is de menstruatie opgehouden^ 
Heeft U een ouikooeratle ondergaan waarna 
de menstruatie wegbleef 
Is de baarmoeder weggenomen _ _ 
Zijn de eierstokken weggenomen „ . _ _ 
Gebruikt U hormoontabletten of Injecties In 
verband met de overgang — . . _ 
ja/nee 
Ja/nee 
ja/nee/onbekend 
ja/nee/onbekend 
ja/nee 
KANKER BIJ FAMILIE 
Komt er kanker voor bij: 
Hoeder van uw vader 
noemer van uw moeder 
Moeder 
Zuster van uw moeder 
Zuster 
Dochter 
U z e l f 
BORSTKANKER 
)a/nee/onbekend 
j a/nee/onbekend 
ja/nee/onbekend 
]a/nee/onbekend 
ja/nee/onbekend 
ja/nee/onbekend 
ja/nee/onbekend 
ANDERE KANKER 
j a/nee/onbekend 
j a/nee/onbekend 
j a/nee/onbekend 
ja/nee/onbekend 
j a/nee/onbekend 
ja/nee/onbekend 
ja/nee/onbekend 
GENEESMIDDELENGEBRUIK 
Hebt U de laatste 12 maanden regelmatig 
geneesmiddelen gebruikt ja/nee 
Zo ja, in verband met 
overgangsklachten 
hoge bloeddruk 
zenuwspanningen „ 
hartafwi jki ngen . 
sui kerziekte 
vermageren 
andere redenen 
welke redenen 
ja/nee 
ja/nee 
ja/nee 
ja/nee 
ja/nee 
ja/nee 
ja/nee 
61 
62 
¿4 
Ui 11 U op het bijgevoegde kaartje de geneesmiddelen vermelden 
welke U regelmatig gebruikt, of dit kaartje thuis invullen 
en on de post doen. 
GA VERDER OP BLA0> 
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MIDDbLbN TbR VOORKOMING VAN ¿WANGtHSCHAP 
Hebt U ooit de pil gebruikt 
Zo ja, m welke periode 
Vult U ook de naam in van de pil op het kaartje 
Gebruikt U nu de pil als tablet 
Krijgt U de 'prikpil" (Imaal per 3 maanden) 
А 
_. 
_ 
tje 
]a/nee 
19 _ tot 
19_ tot 
19- -tot 
_ ja/nee 
_ ja/nee 
19_ _ 
19_ . 
19-_ 
24 
T^-ib 
?9-3ï 
3 > # 
Э7-« 
41 
42 
SCHILDKLILR 
Wordt of werd U behandeld voor een: 
vergrote schildklier (krop» struma) 
gezwel aan de schildklier. 
ontsteking aan de schildklier _ 
te sterk werkende schildklier 
te zwak werkende schi Idkl icr _ 
Andere afwijkingen aan de schildklier 
Komen er afwijkingen van de schildklier voor ïn 
Uw familie (vader, moeder, broer, zuster, kinderen) 
ja/nee 
Ja/nee 
ja/nee 
ja/nee 
ja/nee 
ja/nee 
j a/nee/onbeke nd 
«5 
4G 
SUIKERZIEKTE 
H e e f t U s u i k e r z i e k t e 
Komt er suikerziekte voor in Uw familie (vader, 
moeder , b r o e r , z u s t e r , k i n d e r e n ) - - _ 
]a/nee 
Эа/nee/onbekend 
50 
51 
P^INifH-CTHS 
Da Uiti * dOMij 
ja,пне CHibexend 
«ainig/n ir m βί/νι 
reep. l í V / j 
Ko Inn fc-?3 vior f Ik if bdarl heli«lf<J«. 
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1 st. round 
'^s BEVOLKINGSONDERZOEK BORSTKANKFR NIJMEGEN 
BEOORDELING MAMMOGRAFIE 
В 
volgnummer 
geboortedatum 
onderzoekdatura 
dag 
foto's cranio-caudaal 
(rechts en links) 
24 •/-
ja/nee 
locallsatle 
rÖ-bevlndlncf погшааі voor leeftijd 
7 
el 
R 
1 
25 
2 
5 
3 4 
postmenopausale Lnvolutie_ 
postoperatief 
mastopathie gerinq 
masLopathie ernstig. 
tumor benigne 
tumor onzeker maligne. 
tumor suspect maligne-
tumor zeker maligne 
mastitis 
mast i t i s сагсіпогоа^Еа/1ут£5^ ;іпд_ 
cyste 
advies nader onderzoek 
punctie 
cvtologie van secreet 
biopsie 
met herhalingsonderzoek 
aankruisen wat van toepassing is 
d 
ta 
71 
67 */-
a/nee 
a 
b 
с 
, 
72 
mnd 
5» L 
F 
2 1 
5 
4 3 
7 
— I 
«з_а_ 
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2nd. + 3 rd. round 
Volqnummer L_ 
Gehoortedíi tum L_ 
Onder zoeV da tumL_ 
BFOORDFLING ΙΛΒΟΡΛΝΤΕ 
Palpatie 
palpabele tumor 
localisatie 
Π 31-32 
L 33-34 
Rontqenbevindingen 
normaal voor leeftijd 
mastopathle 
beniqnp tumor 
tumor onzeker maligne 
tumor suspect maligne 
tumor zeker maligne 
Localisâtje : 
1 
2 
3 
4 
5 
6 
1 
2 
3 
4 
5 
6 
1 2 
- 5 
3 I 4 
1
 ff 
2 1 
4 1 3 
35-36 
37-38 
39-40 
41-42 
cranio-caudale foto's 
beoordeling radioloog 
Opmerkingen·. 
За/пее 
ja/nee 
43 
44 
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2nd. + 3rd. round 
BEOORDELING RADIOLOOG 
ПопtqenbevlndIngen 
normaal voor leeftijd 
mastopathle 
beniane tumor 
tumor onzeker maligne 
tumor suspect maligne 
tumor zeker maligne 
1 1 
2 2 
3 3 
4 ~ 
5 5 
6 6 
R 45-46 
I. 47-48 
Loca li satie : 7 Τ 
3 
R 
5 — 
4 
L 
2 
F 
1 
5 — 
4 3 
7 
R 49-50 
L 51-52 
nader onderzoek ja/nee 
Opmerkingen 
copie 
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Werkgroep 
BEVpygNGSONDEBZOEK Bevolkingsonderzoek 
BORSTKANKER Borstkanker 
Hl WfiTH Groenewoudseweg 275 
6524 TV Nijmegen 
T e l e f o o n 080-515150 
Geachte mevrouw, 
U gaat straks deelnemen aan het onderzoek naar 
borstkanker. 
In de folder hebt u gelezen dat er bij dit onder-
zoek röntgenfoto's gemaakt worden van uw borsten 
en dat -als u 50 jaar bent of jonger- uw borsten 
ook met de hand worden onderzocht. 
Voor het onderzoek is het verder van belang dat 
we wat meer van u weten. 
U helpt ons bijzonder als u thuis alvast de vragen 
op de achterzijde van dit formulier invult. 
Wilt u het ingevulde formulier afgeven aan de onder-
zoeksters voordat het eigenlijke onderzoek begint? 
Bij vrijwel alle vragen kunt u ermee volstaan het 
antwoord dat niet van toepassing is door te strepen. 
Hartelijk dank voor uw medewerking. 
Hoogachtend, 
drs.J.H.C.Hendriks, radioloog 
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Niet invullen: RA 14 
Volgnunmer ι ι 
Geboortedatum ι ι 
Onderzoekdatum I L_ 
1-4 
J I 6-11 
_l I 12-17 
J I 10-23 
Over huidige klachten: linkerborst rechterborst 
Heeft u wel eens pijn in uw borsten? ja/nee ja/nee 
Komt er wel eens vocht uit uw 
tepels? 
Heeft u een knobbel in uw borsten? ja/nee 
За/nee 
Heeft u een knobbel in uw oksel? ]a/nee 
Heeft u letsel aan uw borsten door 
een val of een ongeluk? 
Zi;jn er bij u huidveranderingen 
van uw borsten opgetreden? 
Onderzoekt u zelf uw borsten 
regelmatig? 
3a/nee 
3a/nee 
ja/nee 
Hebt u een gespannen gevoel of pijn 
in uw borsten бог uw menstruatie? ja/nee 
Als u klachten hebt, hoe lang hebt 
u die dan al? 
ja/nee 
ja/nee 
ja/nee 
ja/nee 
3a/nee 
3a/nee 
3a/nee 
24-25 
26-27 
28-29 
30-31 
32-33 
34-35 
36-37 
38-39 
weken/maanden/3aren 4 0-42 
Over vroegere klachten, behandeling 
of operatie van de borsten: 
Zijn uw borsten ooit bestraald? 
За/пее 3a/nee 
Hebt u een operatie ondergaan waarbi3 
uw borsten verkleind zijn? за/пее ja/nee 
Zi3n uw borsten operatief, door 
een prothese vergroot? За/пее 
За/пее 
Hebt u een andere operatie aan uw 
bors ten onde rgaan? 
За/пее ja/nee 
In welk ziekenhuis gebeurde dat? .Camsius/Viilhelmina/ 
Radboud/Elders 
Zijn er, buiten een bevolkings­
onderzoek om, wel eens röntgen-
foto's van uw borsten gemaakt? За/пее 
In welk ziekenhuis? Çanisius/Wilhelmina/ 
Radboud/Elders 
Over borstkanker in de familie: 
Is bij uw moeder borstkanker 
geconstateerd? 3a/nee 
Hebt u een zuster bij wie borst-
kanker is vastgesteld? За/пее 
Over het gebruik van geneesiriddelen: 
Gebruikt u hormoontabletten of 
kri3gt u hormoonin3ekties? 
Gebruikt u 'de pil?' 
ja/nee 
За/пее 
43-44 
45-46 
47-48 
49-50 
51 
52 
54 
55 
56 
57 
Appendix H 
BEVOLKINGSONDERZOEK BORSTKANKER 
SINT RADBOUDZIEKENHUIS NIJMEGEN 
Instituut voor Rontgendiagnostiek 
Corr adres Groenevwudseweg 275 
Tel (080) 51 51 50 
Niimegen 
Aan dr 
Zeer geachte Collega 
BIJ UW patiente mevr /mej 
adres 
geboortedatum 
werd op 
een alwiikmg gevonden 
• x ^ 
Ro diagnose | ) waerschi|nli(k benigne 
I I onzeker maligne 
| | suspect maligne 
Γ~] maligne 
Wit adviseren u patiente voor verder onderzoek te verwijzen naar een polikliniek chirurgie van een 
van de Nijmeegse ziekenhuizen en verzoeken u dit formulier na completering aan ons te retourneren 
Opmerhingen 
Dit gedeelte in te vullen door de huisarts 
Aan Werkgroep Borstkankeronderzoek Nijmegen, 
Zeer geachte Collega 
Mijn patiente hierboven genoemd werd door mij 
| | op verwezen naar dr 
chirurg m het St Radboud /St Canisius/Wilhelmma "ziekenhuis 
| | met verwezen wegens uit prakti|k/verhuisd" 
weigering van patiente* 
reeds onder controle/behandeling elders* 
-Naamstempel van de huisarts 
Doorhalen wat met van toepassing is 
Dit exemplaar retour werkgroep 
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Appendix I 
Werkgroep 
BEVpyaNGSOWDBlZD« Bevolkingsonderzoek 
BORSTKANKER Borstkanker 
NUMECEN Groenevroudseweg 275 
6524 TV Nijmegen 
Telefoon 080-515150 
Nijmegen, 
Geachte Mevrouw 
Bi] de beoordeling van de foto's gemaakt tijdens 
het bevolkingsonderzoek, is gebleken dat nader 
onderzoek gewenst is. 
Wij verzoeken u contact op te nemen met uw huisarts, 
die reeds bericht van ons heeft ontvangen. 
Indien uw huisarts afwezig is kunt u contact opnemen 
met het onderzoekcentrum onder nummer 515150. 
Hoogachtend, 
¡J.H.C.L. Hendriks 
radioloog 
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Appendix J 
щ^ 
BEVOLKINGSONDERZOEK BORSTKANKER 
SINT RADBOUDZIEKENHUIS NIJMEGEN 
Instituut voor Rontgendiagnostiek 
Corr adres St Jonsstraat 72 
Tel 10801 51 51 50 
С 
Aan Dr 
Zeef geachte Collega, 
Bi| patiente mevr / m ( x 
Adres 
Geboortedatum 
werd op 
een afwijking gevonden 
Wij verzoeken u onderstaande vragen te beantwoorden en dit formulier ean ons te retourneren met een kopie 
van het rontgenverslag en · voor zover van toepassing een kopie van het operatieverslag 
Is er een tumor in de mammae palpabel 
Zo ja, lokalisatie 
Palpabele grootte. 
7 
Щ 
1 
— 
1 
2 
5 
3 1 4 
2 
4 
L 
Г h 
s 
F 
1 
э 
7 
Zijn er акіііаіге klieren palpabel 
7i|n ftlriftr* kherpn palpabel 
Datum van uw onderzoek 
Re 
іа/пееп 
U 
ia/neen 
ja/neen 
R24 
L33 
B4S 
L49 
Kopie rontgenverslag bijgevoegd _ 
Kopte operatieverslag bijgevoegd 
. ja/neen 
+ -
. ja/neen 
Coiiegiaiiter, J . H . C . L . H e n d r i k e , r a d i o l o o g . 
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Appendix К 
PRINCIPAL ROUTINES OF THE BREAST CANCER SCRFFNINR 
PRniFCT N'lMECFN 
MAMMOGRAPHY 
(1 PROJECTION ) 
SCREENING 
CENTRE SUSPICION OR 
DIFFICULT EVALUATION 
SECOND PROJECTION 
(CRAN CAUD VIEW) 
SUSPICION OF 
MALIGNANCY 
NO SUSPICION OF 
MALIGNANCY GENERAL PRACTIONER 
SURGEON 
• 
CLINICAL EXAMIN 
COMPLETE MAMMOGRAPHY 
HOSPITAL REPEAT EXAM 
3 OR 6 MONTHS 
SUSPICION OF 
MALIGNANCY 
BIOPSY 
• • 
BENIGN MALIGN 
MASTECTOMYi 
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Appendix L 
Histologie nr. 
Ziekenhuis 
Leeftijdsgroep 
Woonplaa ts 
l 1 I I I Bev.Ond.nr. 
Ir tervalnr.. 
Bev.Ond.I 75/76 
» ev.Ond.II 77/78 
bev.Ond.III 79/Θ0 
bev.Ond.IV 61/82 
Behandeling 
Deel­
name 
al I 
і^-п tgen 
1
 ..vindinç 
pôntgen Datum nperatie 
Tu-groottPi Рб-Ond . üatum 
27І L 
J I 
I I I 
« I I I 
з і _ і ι 
ol L_l 
I I I 5S|__I__I S7| L 
Mastectomie 
Rec>ts-Links 
L o c a l i s a t ì e 
Multifocaal 
Ρ.Α.bevinding 
2 
4 
2
 1 
E 
3 
вз| I I 
Lymfeklieren 
Tumor Palpabel 
Bestraling 
Locaal recldief 
eoi I 
71 I L _ 
Overleden/verhuisd 75L 
"ammaca. in famil ie 
Chemotherapie 
731 I I reta's op afstand 
7fi| I | Datum overleden/verhuisd 
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STELLINGEN 
I 
De prognose van borstkanker is op dit moment alleen gunstig te 
beïnvloeden door behandeling in een werkelijk vroeg stadium. 
Henderson, С , Canellos, G Ρ Cancer of the Breast, The Past Decade, part 1, New 
Engl Journ Med 1980,302 17-30 
II 
Er zijn op dit moment geen middelen waarmee mammacarcinoom in 
een vroeger stadium kan worden opgespoord dan met mammografie 
mogelijk is. 
Feig, S A Effect of early breast cancer detection Theory and experience. Reduced 
Dose Mammography Masson Publishing 1979 
III 
De behandeling van cysten in de mamma d.m.v. chirurgische excisie 
is obsoleet. 
Ilaagensen, С D Diseases of the Breast W В Saunders Company, Philadelphia-
London-Toronto sec edit 1971, pag 175 
IV 
Wanneer de thoracale slokdarm overbrugd moet worden, verdient de 
retrosternale maagbuis de voorkeur boven een colon interpositie. 
Joosten, H G M , Plantinga, E R M NTvG 1980,124, 27 1992-1996 
V 
Gezien de aanzienlijke huiddosis die een patiënt ontvangt bij het ma-
ken van een X-tandfilm, 800 mR bij 50 kV en 400 mR bij 65 kV, 
verdient het aanbeveling het gebruik van versterkingsschermen te 
overwegen. De dosis zou hierdoor aanzienlijk kunnen worden ge-
reduceerd terwijl er nauwelijks kwaliteitsverlies optreedt. 
VI 
De diagnostische waarde van de CT-scan van de hersenen, met na-
me die van de coronaire snede, zou sterk verbeterd kunnen worden 
indien in de restauratieve tandheelkunde de amalgaan restauraties 
vervangen zouden worden door de zgn. 'posterieure' composieten, 
waarvan de röntgendensiteit niet hoger is dan die van het tand-
glazuur. 

VII 
De duidelijk gebleken behoefte aan het bestaan van de commissie 
voor bottumoren bewijst, dat specialisatie binnen de radiodiagnostiek 
en interdisciplinaire samenwerking noodzakelijk zijn op alle terreinen 
waar de differentiële diagnostiek moeilijk en belangrijk is. 
VIII 
Een normale gewrichtsspleet op de röntgenfoto sluit ernstige kraak-
beenschade niet uit. 
Berg, ν d , W В , Kruijsen, M W M , Putte, ν d , L B. A , Beusekom, van, H J , 
Sluis ν d-Polv d, M, Zwarts, W A Br J exp Path , 1981, 62, 308-316 
IX 
De mogelijke rol van bloeddrukverhoging t g.v. pneumothorax bij 
het ontstaan van hersenbloedingen bij prematuren is een reden om 
een spannings-pneumothorax zo veel mogelijk te voorkomen door 
tijdige Pleuradrainage. 
X 
Uitspraken van Medische Tuchtcolleges dienen getoetst te zijn aan 
de stand van de wetenschap ten tijde van het gewraakte gebeuren. 
Sturmans, F , Arkel, ν , W G Medisch Contact, 1982, 20 612 
XI 
Bij kinderen met diabetes mellitus dient regelmatig aandacht ge­
schonken te worden aan de lengte van de naald, waarmee de insuline 
wordt geïnjecteerd. 
XII 
Het vermelden in ieder protocol van de woorden Recht en Ethiek op 
een opvallende plaats zou het aantal medische ingrepen drastisch be-
perken. 
26 november 1982 J. H. С L. Hendriks 



